Document:

exv10w3

Exhibit 10.3

Confidential Materials omitted and filed separately with the

Securities and Exchange Commission. Asterisks denote omissions.

BISx INTERNATIONAL LICENSE AGREEMENT

THIS Agreement is made and entered into as of April 14, 2009 (the “Effective Date”), by and between
ASPECT MEDICAL SYSTEMS, INC. (“Aspect”), a Delaware, U.S.A. corporation having offices at One
Upland Road, Norwood, Massachusetts 02062, U.S.A. and Philips Medizin Systeme Böblingen GmbH with
offices at Hewlett-Packard-Strasse 2, 71034 Boeblingen, Germany (“Philips”).

     WHEREAS, Aspect possesses certain intellectual and industrial property rights;

     WHEREAS, Aspect is willing to grant, and Philips desires to acquire, non-exclusive worldwide
rights to use such rights in accordance with the terms and conditions hereinafter set forth; and

     WHEREAS, Aspect and Philips wish to provide Philips customers with a more effective supply of
BIS Sensors (as defined below) at competitive prices.

     NOW, THEREFORE, in consideration of the premises and mutual promises, terms and conditions
hereinafter set forth, and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, Aspect and Philips (the “Parties”) do hereby agree as follows:

	1.	 	DEFINITIONS

As used herein, the following terms shall have the following definitions.

	 	1.1	 	Affiliates. “Affiliates” of a Party hereto shall mean companies which are controlled
by, control or are under common control with such Party. A company shall be considered an
“Affiliate” for only so long as such control exists. For the purposes of this definition,
partnerships or similar entities where a majority-in-interest of its partners or owners
are a Party hereto and/or Affiliates of such Party shall also be deemed to be Affiliates
of such Party.
	 
	 	1.2	 	Agreement Term. “Agreement Term” shall mean the period beginning on the Effective
Date and ending on the date of termination or expiration of this Agreement, as the case
may be.
	 
	 	1.3	 	Aspect Products. “Aspect Products” shall mean those products available for purchase
by Philips and its Affiliates as set forth in Exhibit A (Aspect Products and Purchase
Prices).
	 
	 	1.4	 	BIS. “BIS” shall mean the Bispectral IndexTM which is Aspect’s proprietary processed
EEG parameter that directly measures the hypnotic effects of anesthetic and sedative
agents on the brain.
	 
	 	1.5	 	BIS Engine. “BIS Engine” shall mean Aspect’s processing unit for deriving the BIS
from the raw EEG signal.

 

 

	 	1.6	 	BIS Product. “BIS Product” shall mean the BISx System and/or the BIS Engine, as the
case may be.
	 
	 	1.7	 	BIS Ready. “BIS Ready” shall mean a Philips Patent Monitor with (a) a BIS port
standard on the monitor ready to accept a BISx System, with BIS software installed on the
host monitor, or (b) at least one available multi-connector port if such a dedicated BIS
port is not utilized.
	 
	 	1.8	 	BIS Sensor. “BIS Sensor” shall mean a single use disposable or semi-reusable sensor
manufactured by Aspect for use with the BISx System or the BIS Engine/DSC-XP in the OR,
ICU and other sedation locations that is required to generate Aspect’s Bispectral Index.
These sensors include the BIS Quatro Sensor, the BIS Extend Sensor and the BIS Pediatric
Sensor.
	 
	 	1.9	 	BISx. “BISx” shall mean a device that acquires up to two channels of EEG and
computes BIS and other EEG parameters, uniting the functionality of the existing Aspect’s
BIS Engine and DSC-XP. BISx shall include enhancements and new features relating to
consciousness monitoring that are made generally available by Aspect during the term of
this Agreement.
	 
	 	1.10	 	BISx System. “BISx System” shall mean the system comprised of a BISx device with a
Monitor Cable and a Patient Interface Cable (“PIC”) designed for use with the Philips
Patient Monitor and is also known, including in Exhibit A, as a “BISx Kit”.
	 
	 	1.11	 	Business Day. “Business Day” shall mean a day on which Aspect’s offices are open for
business in Norwood, Massachusetts, U.S.A., and on which Philips’ offices are open for
business in Boeblingen, Germany.
	 
	 	1.12	 	Contract Year. “Contract Year” shall mean the 12-month period commencing on the
Effective Date, and then each 12-month period thereafter.
	 
	 	1.13	 	Documentation. “Documentation” shall mean any and all user manuals, programmer’s
guides, configuration guides, circuit diagrams, and help files related to the Software.
	 
	 	1.14	 	DSC-XP. “DSC-XP” shall mean Aspect’s digital signal converter using XP technology.
The DSC-XP is a small box that is kept close to the patient that converts the analog EEG
signals to digital signals for processing the BIS value.
	 
	 	1.15	 	Intellectual Property Rights. “Intellectual Property Rights” shall mean all forms of
protection afforded by law to inventions, models, designs or technical information, and
applications therefor or which otherwise arise or are enforceable under the laws of the
United States, any other jurisdiction or any bi-lateral or multi-lateral treaty regime,
including, but not limited to, any and all patents and patent applications (including
additions, reissues, divisionals, continuations, continuations-in-part, substitutions,
re-examinations, patent term extensions, registrations, supplemental protection term
certificates, and renewals

 

 

	 		 	of any of the foregoing), utility models, trademarks, trade
secrets, registered and
unregistered designs including mask works, copyrights, and moral rights.

	 	1.16	 	IntelliVue Clinical Network. “IntelliVue Clinical Network” shall mean the software
that enables wireless and wire line communications transmission of physiologic measurement
data between Philips IntelliVue bedside monitors, central stations, applications servers,
database servers and telemetry devices.
	 
	 	1.17	 	Licensed Technology. “Licensed Technology” shall mean the Aspect Products, the
Software, Documentation and the Technical Information.
	 
	 	1.18	 	License Term. “License Term” shall mean the period beginning on the Effective Date
and ending on the date of termination or expiration of this Agreement, as the case may be.
	 
	 	1.19	 	Material Product Change. “Material Product Change” shall mean any of the following
changes to a BIS Product or any component thereof:

	 	(a)	 	BIS Product or service design changes that affect regulatory
compliance or safety or materially affect form, fit, function, reliability,
serviceability, performance, functional interchangeability or interface
capability of the BIS Product;
	 
	 	(b)	 	production process changes that materially affect design
and/or production specifications;
	 
	 	(c)	 	change of manufacturing facility location or change of
ownership of the manufacturing facility (to the extent such change in
ownership is known to Aspect);
	 
	 	(d)	 	changes that modify Aspect’s quality system beyond editorial
enhancements or continuous efficiency improvements in workflows; or
	 
	 	(e)	 	changes to regulatory status (including environmental
compliance status) which affect any certification of Aspect or the
manufacturing facility for the BIS Product.

	 	1.20	 	Monitor Cable. “Monitor Cable” is a cable that connects the BISx to the Philips
Patient Monitor and is also known, including in Exhibit A, as a “Host Cable”. The Monitor
Cable connector will be supplied by Aspect or its manufacturer using designs supplied by
Philips for final assembly with the BIS Products.
	 
	 	1.21	 	“Open Source Software” shall mean any software that is licensed under Open License
Terms.
	 
	 	1.22	 	“Open License Terms” shall mean terms that require as a condition of use,
modification and/or distribution of a work:

1. the making available of source code or other materials preferred for
modification, or

2. the granting of permission for creating derivative works, or

 

 

3. the reproduction of certain notices or license terms in derivative works or
accompanying documentation, or

4. the granting of a royalty-free license to any party under Intellectual Property
Rights regarding the work and/or any work that contains, is combined with or
otherwise is based on the work.

	 	1.23	 	Philips Patient Monitor. “Philips Patient Monitor” shall mean all Philips
multi-parameter patient monitors designed by Philips to accept a BIS Product.
	 
	 	1.24	 	Software. “Software” shall mean Aspect software programs that are integrated into the
BIS Product.
	 
	 	1.25	 	Technical Information. “Technical Information” shall mean the trade secrets,
know-how, computer programs (including copyrights in said software), knowledge,
technology, means, methods, processes, practices, formulas, techniques, procedures,
technical assistance, designs, drawings, apparatus, written and oral rectifications of
data, specifications, assembly procedures, schematics and other valuable information of
whatever nature, whether confidential or not, and whether proprietary or not, which is now
(or hereafter, during the Agreement Term, becomes) licensable by Aspect and which is
necessary for Philips’ integration, sale, distribution, use, installation, servicing or
testing of an Aspect Product as permitted under this Agreement.
	 
	 	1.26	 	U.S. Dollars. “U.S. Dollars” shall mean lawful money of the United States of America,
in immediately available funds.
	 
	 	1.27	 	Philips BIS Products Solution. “Philips BIS Products Solution” shall mean the BIS
Products in combination with Philips Patient Monitors.

	2.	 	LICENSES TO INTELLECTUAL PROPERTY

	 	2.1	 	Licenses.

	 	(a)	 	For the term of this Agreement, subject to the terms and
conditions of this Agreement, Aspect agrees to sell and Philips agrees, on
behalf of itself and its Affiliates, to purchase the Aspect Products listed
in Exhibit A (Aspect Products and Purchase Prices) and each Party agrees to
negotiate an amendment to Exhibit A to include BIS-x4 when available
(including the negotiation of the price thereof).
	 
	 	 	 	The Aspect Products purchased from Aspect under this Agreement shall only be
used as part of, incorporated into, or integrated with, systems and products
of Philips which Philips, its Affiliates, distributors or sub-distributors
sell or lease to third-party users in the regular course of business.
Philips, its Affiliates, distributors or sub-distributors shall only sell
Aspect-approved accessories in connection with any BIS Product. Aspect
agrees to provide Philips with all information in its possession that

 

 

	 	 	 	is necessary for the interfacing and operation of the BIS Products with
Philips Patient Monitors. Aspect agrees to provide Philips with information
in its possession that will allow Philips to provide Aspect
Products-specific service and support to the end-user.

	 	(b)	 	Subject to the terms and conditions of this Agreement,
during the term of this Agreement and, thereafter, solely as provided in
Section 12.3(b)(i), Aspect hereby grants Philips a non-exclusive and
non-transferable world-wide license (i) with the right to sublicense solely
to Philips’ Affiliates, distributors and sub-distributors, to import, and
(ii) with the right to sublicense solely to Philips’ Affiliates,
distributors, sub-distributors and customers, to use, display and copy the
Software provided by Aspect solely in connection with the sale and operation
of the Aspect Products for use with a Philips Patient Monitor.
	 
	 	(c)	 	Subject to the terms and conditions of this Agreement,
during the term of this Agreement and, thereafter, solely as provided in
Section 12.3(b)(i), Aspect hereby grants Philips a non-exclusive and
non-transferable world-wide license (i) with the right to sublicense solely
to Philips’ Affiliates, distributors and sub-distributors, to copy, make
alterations and derivative works, sell copies of, distribute, and import the
Documentation provided by Aspect, and (ii) with the right to sublicense
solely to Philips’ Affiliates, distributors, sub-distributors and customers,
to use and display such Documentation and the derivative works thereof
created in accordance with clause 2.1(c)(i), in each case solely in
connection with the sale and operation of the Aspect Products for use with a
Philips Patient Monitor.
	 
	 	(d)	 	All rights granted to customers to use the Software and
Documentation with the Aspect Products shall survive any termination of the
Agreement as long as the Software and Documentation is distributed to
customers who are bound by terms at least as protective of the Software and
Aspect’s Intellectual Property Rights therein as the terms set forth in
Sections 2.1(e) and 2.1(f) of this Agreement; Philips shall be responsible
for communicating these requirements to its customers and the customers of
its Affiliates, distributors and sub-distributors. Any sublicense to a
customer to use the Software and Documentation shall automatically terminate
on the customer’s breach of any of the terms set forth in Section 2.1(e) or
2.1(f).
	 
	 	(e)	 	Philips shall not, without the express written consent of
Aspect, disassemble, decompile or otherwise reverse engineer the Aspect
Products or any part thereof (including the Software). Philips agrees to
obligate its distributors, sub-distributors, its Affiliates and purchasers of
Aspect Products not to disassemble, decompile or otherwise reverse engineer
the Aspect Products or any part thereof without the express written consent
of Aspect. If applicable law requires that Philips or any of its
distributors, sub-distributors, Affiliates or customers have access to the
source code of the Software, Philips shall notify Aspect if any such party
desires such access and Aspect shall have the option to (i) perform the work
to derive any required information at Aspect’s usual consulting rate, payable
by

 

 

	 	 	 	such party, or (ii) allow such party to access the source code solely for
the legally required purpose.
	 
	 	(f)	 	Title to and ownership of any and all proprietary rights in
or related to the Software and Documentation thereof shall at all times
remain with Aspect or its licensor(s). Nothing in this Agreement shall be
construed as a sale of any rights in the Software or Documentation. Any
references in this Agreement to sale, resale or purchase of the Aspect
Products, or similar references, shall, with respect to the Software and the
Documentation, mean licenses of the Software and Documentation pursuant to
Sections 2.1(b) and (c).
	 
	 	(g)	 	Philips and its customers shall have the right to create a
reasonable number of backup copies of the Software, Documentation and any
Technical Information solely for disaster recovery and/or contingency
purposes.

	 	2.2	 	Use of Technical Information.
	 
	 	 	 	Subject to the terms and conditions of this Agreement, Aspect grants to Philips a
paid-up, non-exclusive worldwide right and license, with the right to sublicense
solely to Philips’ Affiliates, during the Agreement Term to use, display, copy and
import the Technical Information in connection with the exercise by Philips and
its Affiliates of its rights and licenses granted in Section 2.1, and for no other
purpose and Philips may distribute such Technical Information to its Affiliates
solely for such purpose. All Technical Information shall be considered to be the
Proprietary Information of Aspect for the purposes of Section 8.
	 
	 	2.3	 	Philips Trademarks, Service Marks, and Trade Names.
	 
	 	 	 	Philips on behalf of its ultimate parent Koninklijke Philips Electronics NV
(“KPENV”) hereby grants Aspect a non-exclusive license under those certain
trademarks as listed on Exhibit F (the “Philips Trademarks”) for the sole purpose
of promoting the Aspect Products in promotional material, advertisement and/or in
written technical literature [**] (“Purpose”). Such license is granted provided
Aspect fully satisfies all of the provisions relating to/imposed on Aspect as set
forth below:

	 	(a)	 	Aspect in its use of the Philips Trademarks shall
adhere to the trademark guidelines of Philips and KPENV;
	 
	 	(b)	 	Aspect shall use the Philips Trademarks consistent
and solely in accordance with the Purpose;
	 
	 	(c)	 	Aspect shall use the Philips Trademarks only at
trade shows and for advertising within brochures and marketing materials
(“Licensed Use”);
	 
	 	(d)	 	Aspect shall not use the Philips Trademarks without
Philips’ prior written permission wherein permission must be agreed to by
Philips for
each type of Licensed Use;

 

 

	 	(e)	 	Aspect agrees to use the Philips Trademarks only in
the form and manner provided and approved by Philips;
	 
	 	(f)	 	Aspect shall make available to Philips a sample of
each type of Licensed Use (final version) for purposes of verification of
usage being in accordance with the terms and conditions of this Section
2.3.
	 
	 	(g)	 	Notwithstanding anything to the contrary in this
Section 2.3, (i) Aspect may identify Philips as a customer of Aspect,
including without limitation on Aspect’s web site during the Agreement
Term, the form and content of which is subject to Philips’ review and
approval as set forth in this Section 2.3, such approval not to be
unreasonably withheld or delayed; and (ii) all promotional material,
advertisements and/or written technical literature using Philips
Trademarks that were previously developed and approved by Philips under
the agreement dated the 6th day of August, 1999, by and between Aspect
and Philips (formerly Hewlett-Packard GmbH), as amended through the
Effective Date (“1999 Agreement”) during the period from January 1, 2007
until the Effective Date of this Agreement shall remain approved under
this Agreement;
	 
	 	(h)	 	Philips hereby reserves all rights, title and
interest in and to the Philips Trademarks not specifically granted
herein;
	 
	 	(i)	 	Philips shall at all times, anywhere in the world,
and whether or not in competition with Aspect, have the right to use
and/or authorize the use of the Philips Trademarks, or any portion
thereof, in any way Philips may desire;
	 
	 	(j)	 	Aspect shall indemnify, defend and hold Philips,
and all other legal entities which are, directly or indirectly, owned or
controlled by KPENV and all of each of their respective officers,
directors and employees harmless from and against any and all losses,
costs, claims, damages (including court costs and attorney’s fees),
liability, demands or expenses, which may arise out of or derive in any
way from Aspect’s use of the Philips Trademarks except in the event of a
breach of the representations or warranties by Philips as set forth in
this Section 2.3. Philips hereby agrees to defend, indemnify and hold
Aspect harmless from any claims arising out of Philips breach of any
representations, warranties or agreements as set forth in this Section
2.3;
	 
	 	(k)	 	Philips represents and warrants that the use of the
licensing rights under the Philips Trademarks granted to Aspect under
this Section 2.3 shall not infringe upon the common law or statutory
trademark rights of any third parties;

 

 

	 	(l)	 	Aspect agrees that it will do nothing inconsistent
with the ownership of the Philips Trademarks by KPENV and that all uses
of same shall inure to the benefit of and be on behalf of KPENV;
	 
	 	(m)	 	Aspect agrees that nothing in this Agreement shall
give Aspect any right, title or interest in the Philips Trademarks other
than the right to use the Philips Trademarks in accordance with this
Section 2.3;
	 
	 	(n)	 	Philips shall have the sole right and discretion to
bring infringement or unfair competition proceedings involving the
Philips Trademarks. Under no circumstances shall Aspect take any action
or has any right to enforce Philips’s rights in the Philips Trademarks;
	 
	 	(o)	 	Aspect’s license of the Philips Trademarks in
accordance with this Section 2.3 is expressly conditioned on Aspect’s
execution and delivery of this Agreement and continued compliance with
the terms of this Section 2.3. Philips may terminate this Agreement
immediately if Aspect breaches any term or condition contained in this
Section 2.3 which has not been cured within thirty (30) days after
written notice of breach is delivered to Aspect. Aspect agrees to
immediately discontinue the use of the Philips Trademarks if such cure is
not complete within this thirty (30) day time period. Aspect further
agrees that upon termination of this Agreement, all rights in the Philips
Trademarks and the goodwill connected therewith shall remain the property
of KPENV;
	 
	 	(p)	 	In the event that Philips decides, at its sole
discretion, as a result of a cease and desist demand from a third party
(or an agreement resulting therefrom) or a judicial order to cease and
desist from using any one or more of the Philips Trademarks, Aspect shall
immediately cease using said any one or more of the Philips Trademarks;
	 
	 	(q)	 	Aspect shall not use any other trademark in
combination with any of the Philips Trademarks without prior written
approval of Philips which shall be in Philips’ sole discretion; and
	 
	 	(r)	 	In the event of expiration or termination of this
Agreement, the licensing rights under the Philips Trademarks of this
Section 2.3 immediately terminates. Upon termination of this Agreement
any reference to Philips and its trademarks must be promptly removed
from any literature or other display and any existing literature
containing any reference to Philips and its trademarks must no longer be
distributed. Aspect may not use the Philips Trademarks in connection
with the delivery by Aspect of any services.

	 	2.4	 	Aspect Trademarks, Service Marks and Trade Names.

	 	(a)	 	Aspect hereby grants Philips the right to use the
trademarks, service marks and trade names claimed by Aspect listed in Exhibit
E hereto, as may be

 

 

	 	 	 	amended from time to time by mutual agreement of the Parties’ respective
relationship managers (the “Aspect Trademarks”) on a non-exclusive basis only
for the License Term and solely for display or advertising purposes in
connection with the Aspect Products manufactured and sold in accordance with
this Agreement, the form and content of which is subject to Aspect’s review and
approval, such approval not to be unreasonably withheld or delayed. All
display and advertising material using the Aspect Trademarks that were
developed and approved under the 1999 Agreement shall remain approved under
this Agreement. During the License Term, Philips and its Affiliates may also
use, without Aspect’s prior written consent, Philips or third-party trademarks,
service marks and trade names other than the Aspect Trademarks in connection
with the BIS Products; provided, however Philips shall, and shall ensure that
its Affiliates, will make reasonable efforts to use the Aspect Trademarks in a
manner which makes them at least as large and prominent as any other similar
third party trademarks, service marks, or trade names appearing on any such
label, display or advertisement. Philips may not use the Aspect Trademarks in
connection with the delivery by Philips of any services.

	 	(b)	 	Philips and its Affiliates shall be required to mark those
Philips Patient Monitors that are BIS Ready with Aspect’s “BIS Ready” logo in
form of a laser printed, printed, or sticky label. The marking will be of a
mutually agreeable size and will be placed at a mutually agreeable location
on such Philips Patient Monitor. Notwithstanding the foregoing, if no
mutually agreeable place or size can be determined then Philips’ labeling
obligations shall be considered fulfilled with providing one loose sticky
label “BIS Ready” with each such monitor shipped. Aspect shall provide the
required number of “BIS Ready” sticky labels to Philips free of charge.
	 
	 	(c)	 	Each of Philips and its Affiliates shall

	 	(i)	 	whenever it uses the Aspect Trademarks in any
technical literature, product literature or advertisement, include a
statement at least once in each piece of literature that the Aspect
Trademarks are trademarks claimed by Aspect;
	 
	 	(ii)	 	use the Aspect Trademarks in compliance with Aspect’s
guidelines for using the Aspect Trademarks;
	 
	 	(iii)	 	not modify any of the Aspect Trademarks in any way
and not use any of the Aspect Trademarks on or in connection with any
goods or services other than the Aspect Products.

	 	2.5	 	Right to Sublicense.
	 
	 	 	 	Except as agreed to subject to the terms of this Agreement, Philips shall not have
the right to sublicense any of the rights or licenses granted hereunder without
Aspect’s prior written consent in Aspect’s sole discretion; provided, however it is
understood that Philips shall have the right to grant sublicenses consistent with
the terms and conditions of this Agreement to Philips’ Affiliates, distributors,
sub-distributors, and customers without Aspect’s prior written consent,

 

 

	 	 	 	provided, however, that Philips shall not have the right to grant any sublicense to
customers under the Aspect Trademarks.

	 	2.6	 	No Rights by Implication.
	 
	 	 	 	No rights or licenses with respect to Licensed Technology are granted or deemed
granted hereunder or in connection herewith, other than those rights or licenses
expressly granted in this Agreement.
	 
	 	2.7	 	Software and Computer Programs.
	 
	 	 	 	Philips shall retain and shall not, without the express written consent of Aspect,
alter or obscure any notices, markings or other insignia which are affixed to the
Software, the Documentation or any part thereof at the time of delivery of such
Software or such Documentation. The Software shall be considered to be the
Proprietary Information of Aspect for the purposes of Section 8.
	 
	 	2.8	 	Limited Warranty.
	 
	 	 	 	Aspect represents and warrants to Philips that, as of the Effective Date, Aspect
knows of no claim by any third-party of infringement by Aspect on such party’s
patent, trademark, copyright, trade secret or other Intellectual Property Rights
covering the Aspect Products, Software, Documentation, or Technical Information.
Aspect further represents and warrants that it owns all right, title, and interest
in and to the Aspect Products, Software, Documentation, and Technical Information,
including all Intellectual Property Rights thereto, or has the full lawful right to
grant the licenses to the Licensed Technology as set forth herein.
	 
	 	2.9	 	DISCLAIMER OF WARRANTY.
	 
	 	 	 	EXCEPT FOR THE EXPRESS WARRANTIES SET FORTH HEREIN, INCLUDING BUT NOT LIMITED TO
EXHIBIT D, ASPECT MAKES NO OTHER EXPRESS OR IMPLIED WARRANTY, STATUTORY OR
OTHERWISE, CONCERNING THE LICENSED TECHNOLOGY OR ANY OTHER INFORMATION COMMUNICATED
TO PHILIPS, INCLUDING WITHOUT LIMITATION NO WARRANTY OF FITNESS FOR A PARTICULAR
PURPOSE, AND NO WARRANTIES AS TO QUALITY OR THE USEFULNESS OF THE LICENSED
TECHNOLOGY FOR ITS INTENDED PURPOSE.

	3.	 	CHANGES TO BIS PRODUCTS AND PATIENT MONITORS

	 	3.1	 	Notifications of Changes to BIS Products.
	 
	 	 	 	Aspect shall have the right, at any time and from time to time, to make
substitutions and modifications to BIS Products that, in Aspect’s reasonable
judgment, do not constitute Material Product Changes, and Aspect shall not be
required to provide Philips with notification of any such substitutions or
modifications.
	 
	 	3.2	 	Material Product Changes.
	 
	 	 	 	In the event that any proposed substitution or modification is expected by Aspect
to be a Material Product Change, Aspect shall give Philips written notice of such

 

 

	 	 	 	proposed substitution or modification as early as possible in the development
process, but in any case no later than the earlier of (i) at least [**] days prior
to the planned release of such change if no significant changes are likely to be
required to be implemented by Philips in Philips Patient Monitors, or (iii) at
least [**] prior to the planned release of such modifications if significant
changes are also likely to be required to be implemented by Philips in Philips
Patient Monitors. If Philips does not provide written approval of any such
proposed changes (which approval shall not be unreasonably withheld) Aspect shall
continue to deliver the unchanged version of the BIS Product for at least [**]
according to the regular forecast mechanism and, [**] prior to the termination of
supply, offer Philips a final opportunity to purchase up to [**]% of the volume
ordered in the previous [**]. Aspect shall provide the appropriate verification and
validation information for evaluating the effect of the change on the BIS Products.

	 	3.3	 	Required Changes.
	 
	 	 	 	Notwithstanding anything contained in this Agreement to the contrary, Aspect
reserves the right from time to time during the License Term to require Philips,
after consulting with Philips, to modify or improve any Aspect Product (including
without limitation the software programs used in connection with the BIS Product)
if the modification or improvement reasonably relates to efficacy or patient
safety. Provided that such modifications are feasible and commercially reasonable,
Philips shall implement those modifications to the BIS Products and associated
Philips Patient Monitors being manufactured or to be manufactured and to modify and
improve BIS Products previously manufactured and shipped to customers in order to
incorporate such changes on a schedule at Philips’ reasonable discretion. If such
modifications, improvements, or changes are implemented by Philips, it will be with
Aspect’s reasonable assistance and, to the extent that the required change is
caused by the BIS Product (other than the Monitor Cable), at Aspect’s expense.
	 
	 	3.4	 	Notification of Discontinuance.
	 
	 	 	 	Aspect agrees to notify Philips in writing not less than [**] in advance of the
discontinuance of any BIS Product. Philips shall be able to place orders for [**]
after receipt of the written notice in any case. In addition, Philips shall be
entitled to determine its lifetime-buy quantities and place a corresponding last
purchase order no later than [**] prior to the planned obsolescence date.

	4.	 	INCIDENT REPORTING AND CORRECTIVE ACTIONS

	 	4.1	 	Aspect shall immediately, but no later than within 48 hours, provide Philips with a
written notice upon Aspect becoming aware of the occurrence of any of the following
events: (i) Aspect recalls any BIS Product, or ceases or suspends the sale of any BIS
Product due to any problem which relates to such BIS Product’s efficacy or patient safety
in any country; (ii) any defect of any Licensed Technology, which relates to such BIS
Product’s efficacy or patient safety, is published, publicly reported or made known to the
public by any third party, or found by or reported to Aspect; or (iii) any Licensed
Technology is determined
to have contributed to or caused a death or serious injury.

 

 

	 	4.2	 	Philips shall immediately, but no later than within 48 hours, provide Aspect with a
written notice upon Philips becoming aware of the occurrence of any of the following
events: (i) Philips identifies the need to recall its BIS Products, or ceases or suspends
the sale of its BIS Products due to any problem which Philips believes relates to such BIS
Product’s efficacy or patient safety in any country, it being understood that any decision
to proceed with a recall of BIS Products sold hereunder shall not be made by Philips
before consulting with Aspect; (ii) any defect of any BIS Product or the Licensed
Technology, which relates to such BIS Product’s efficacy or patient safety, is published,
publicly reported or made known to the public by any third party, or found by or reported
to Philips; or (iii) any BIS Product or the Licensed Technology is determined to have
contributed to or caused a death or serious injury, or any BIS Product or the Licensed
Technology malfunctioned and if that malfunction occurred again, it would be likely to
contribute to or cause a death or serious injury.
	 
	 	4.3	 	Aspect, itself or through its Affiliates, is responsible for determining complaints
and Medical Device Reporting (“MDRs”) and related submissions to the FDA and other
regulatory authorities for the BIS Products. Philips, itself or through its Affiliates,
is responsible for determining complaints and MDRs and related submissions to the FDA and
other regulatory authorities for the Philips BIS Products Solution (other than the BIS
Products).
	 
	 	4.4	 	Subject to the provisions of Sections 4.1, 4.2 and 4.3 above, Philips is responsible
for the overall Philips BIS Products Solution and is therefore responsible to perform
recalls and corrective actions with respect thereto.
	 
	 	4.5	 	Any corrective action will be at Philips’ expense if clearly caused by the Philips
Patient Monitor. Philips will reimburse Aspect for Aspect’s documented cost directly
resulting from such corrective actions within 60 days of completion of the corrective
action.
	 
	 	4.6	 	Aspect will reimburse Philips for Philips’ documented cost directly resulting from
such corrective actions within 60 days of completion of the corrective action if clearly
caused by any BIS Product, as described in Exhibit B.
	 
	 	4.7	 	Philips and Aspect will share the cost if both Parties’ products contribute to the
cause, proportionate to the extent of each Party’s respective degree of cause as mutually
agreed. Aspect’s Vice President of Regulatory and Quality Affairs and a senior business
director, together with the most senior executive with regulatory responsibility and a
senior business director from Philips Healthcare Informatics/Patient Monitoring business
unit, will negotiate in good faith a reasonable settlement of the issue. If after twenty
(20) Business Days, the Parties in good faith fail to agree the issue will be escalated
for resolution in accordance with Section 13.4(b).

 

 

	5.	 	PRODUCT DEVELOPMENT (BIS PRODUCTS AND MONITOR CABLE)
	 
	 	 	The existing implementation of BIS in Philips Patient Monitors utilizing the BIS Products has
been developed under a previous development contract. Both Parties anticipate that there
will be advances in the BIS technology over time and agree that reasonable efforts should be
made, if mutually agreed, to keep the Philips BIS implementation up-to-date according to the
latest Aspect technology and performance. Therefore, an ongoing project is established
between the companies to cover these ongoing improvement efforts.

	 	5.1	 	Project Management.

	 	5.1.1	 	Each Party shall appoint a “Project Manager” who shall oversee and
manage the joint R&D project on a day-to-day basis.
	 
	 	5.1.2	 	The Project Managers shall meet regularly based on the project needs to
assess the project status and discuss and resolve any issues or problems. These
meetings may be held face-to-face or as telephone or videoconferences.
	 
	 	5.1.3	 	Each Party shall bear its own development, communication and travel costs.

	 	5.2	 	Philips Development Responsibilities.
	 
	 	 	 	Philips will be responsible for any changes (design or material) to the Philips Patient
Monitor to integrate the BIS Products with the Philips Patient Monitor and the
visualization of BIS data. This includes the Philips Patient Monitor connector and the
appropriate communication software to interface the BIS Products with Philips Patient
Monitors.

	 	5.2.1	 	Philips will be responsible for the necessary Philips Patient Monitors
hardware and software (changes, upgrades, maintenance) to allow the user to
configure BIS parameters, to display the BIS-related information on the Philips
Patient Monitor display, and to pass on BIS-related data through the IntelliVue
Clinical Network and other Philips Patient Monitor outputs.
	 
	 	5.2.2	 	Philips shall make reasonable commercial efforts to follow Aspect’s
guidelines and recommendations concerning processing and visualization of BIS data
with respect to the operation and visualization logic, philosophy and visual,
audible and haptic experience (“look-and-feel”) of Philips Patient Monitors and
other Philips products that store, process, display or provide patient data.
	 
	 	5.2.3	 	Philips shall be responsible for testing and validation of the BIS
Products integration with the Philips Patient Monitors.
	 
	 	5.2.4	 	Depending on the complexity of the connector assembly, Philips
acknowledges, subject to good faith negotiation and mutual agreement of the Parties,
that it may be involved in the manufacturing and assembly process of any new Monitor
Cable required to interface Philips Patient Monitors with the BISx System.
	 
	 	5.2.5	 	Philips shall assume regulatory responsibility for the combination of
the BIS Products with Philips Patient Monitors as provided in Section 9 of this
Agreement.

 

 

	 	5.3	 	Aspect Development Responsibilities.

	 	 	 	For changes to the current BIS Products, Aspect shall provide Philips with the
necessary Technical Information to support the integration of the new or modified
BIS Products with Philips Patient Monitors. This includes information to
facilitate the development and/or refinement of a Philips Patient Monitor
connector, of an appropriate communications software to interface the BIS
Products to the Philips Patient Monitors, and of an appropriate user interface
for BIS in the Philips Patient Monitor. Aspect shall inform Philips and provide
said Technical Information as early in the development process as possible, in
any case no later than (i) any other Aspect partner (who has an agreement with
similar terms and conditions as this Agreement) gets informed about the plans and
specifications, (ii) six (6) months prior to commercial availability for any
change that may affect the specifications and documentation of the Philips BIS
Products Solution, or (iii) twelve (12) months prior to commercial availability
for any change that requires changes in the Philips Patient Monitors as well.
	 
	 	5.3.1	 	Aspect shall design, develop and test the BIS Products according to the
mutually agreed upon specifications.
	 
	 	5.3.2	 	Aspect shall make commercially reasonable efforts to maintain backward
compatibility with installed base Philips Patient Monitors for any new or changed
BIS Products and/or 2-channel BIS sensors.
	 
	 	5.3.3	 	Upon Philips completing the integration of the BIS Products into a
Philips Patient Monitor (including when any new model of a BIS Ready Philips Patient
Monitor is developed/introduced), Aspect will “certify” this integration. This
entails Aspect verifying the accurate display on the Philips Patient Monitor. Once
successfully verified, Aspect will provide Philips with a letter so certifying. To
facilitate the certification process, Philips will lend to Aspect a Philips Patient
Monitor for testing purposes. Said Philips Patient Monitor will be provided to
Aspect, at Philips’ cost and expense, within thirty (30) days after execution of
this Agreement, and will be kept updated by Philips to the latest available state as
far as the BIS functionality is concerned. Aspect will return such equipment to
Philips, at Aspect’s cost and expense, within thirty (30) days after termination of
this Agreement.

	6.	 	SALES BY ASPECT TO PHILIPS

	 	6.1	 	Offer and Acceptance; Pricing. Philips’ and its Affiliates’ purchases of
Aspect Products during the first calendar year shall be at the prices set forth in Exhibit
A (Aspect Products and Purchase Prices), except as noted in Sections 6.2 and 6.4. The
Parties have agreed, subject to applicable law, to initiate at least once a year
discussions on market conditions and trends as well as transfer pricing of Aspect
Products.
	 
	 	6.2	 	Additional costs which have been agreed upon in writing (both NRE and incremental
unit cost) for customization of the BIS Products (mold color, labeling) will be borne by
Philips. Philips shall be responsible for any charges associated with scrap of inventory
due to any subsequent changes made to any
BIS Product that were initiated by Philips.

 

 

	 	6.3	 	For each purchase by Philips or its Affiliates from Aspect, Philips or such Affiliate
shall present a purchase order to Aspect (a “Purchase Order”). Each Purchase Order shall
be deemed an offer to purchase and, unless Philips or such Affiliate is notified in
writing to the contrary within five (5) Business Days after Aspect receives it, such
Purchase Order shall be deemed accepted by Aspect.
	 
	 	6.4	 	Aspect’s sale prices shall be FCA (Incoterms 2000) Norwood, Massachusetts, U.S.A. The
initial prices set forth in Exhibit A (Aspect Products and Purchase Prices) are based on
current material and labor costs for the Aspect Products. Starting with the second
(2nd) Contract Year, Aspect may increase the then current sale prices if
Aspect’s actual manufacturing cost of the Aspect Products increases from the current cost
by more than [**]%; provided, however that: (i) such change may be made only [**]
effective as of the first day of April with the prior written notice to be given by Aspect
no later than the last day of December of the preceding year, after consulting with
Philips; and (ii) the annual increase shall be [**], based on evidence provided to Philips
by Aspect. Aspect may [**] at any time during the year with immediate effect by giving
Philips written notice. No price change shall affect Purchase Orders offered by Philips
and accepted by Aspect prior to the date such price change becomes effective
	 
	 	6.5	 	Delivery.
	 
	 	 	 	Unless Philips requests otherwise, all Aspect Products ordered by Philips shall be
packed for shipment and storage in accordance with Aspect’s standard commercial
practices. It is Philips’ obligation to notify Aspect of any special packaging
requirements (which shall be at Philips’ expense if such requirement is in excess
of the scope of normal and necessary packaging for export). Aspect shall deliver
BIS Products into the possession of a common carrier designated by Philips or its
Affiliate, in Norwood, Massachusetts, U.S.A. no later than the date specified for
such delivery on the relevant Purchase Order. Risk of loss and damage to a BIS
Products shall pass to Philips or its Affiliate upon the delivery thereof to the
common carrier designated by Philips or such Affiliate. If Philips or its Affiliate
does not designate a common carrier by the specified delivery date, then Aspect may
do so on Philips’ or its Affiliate’s behalf. All claims for non-conforming
shipments must be made in writing to Aspect within thirty (30) days of the passing
of risk of loss and damage; any claims not made within this time period shall be
deemed waived.
	 
	 	6.6	 	Forecast.
	 
	 	 	 	Philips shall furnish to Aspect a non-binding quarterly forecast during the term of
this Agreement with the number and type of BIS Products for which Philips expects
to submit orders for the following [**].
	 
	 	6.7	 	Sales Reporting.

	 	6.7.1	 	Philips will report the number of BIS Products sold by
Philips, or its Affiliates by hospital (where possible) on a quarterly basis .
Should hospital-level data not be available to Philips, Philips will then
report BIS Products sold at the next most accurate level, e.g. distributor
name, location).

 

 

	 	6.7.2	 	K-Options. Philips will provide detail of K-Options (as
defined in Exhibit A) sold by Philips or its Affiliates by hospital (where
possible).Should hospital-level data not be available to Philips, Philips will
then report K-Options sold at the next most accurate level, e.g. distributor
name, location.

	 	6.8	 	Method of Payment.
	 
	 	 	 	All amounts due and payable with respect to Aspect Products delivered by Aspect in
accordance with this Section 6 shall be paid in full within [**] days from the end
of the month of the date of Aspect’s invoice therefor. All such amounts shall be
paid in U.S. Dollars by wire transfer, to such banks or accounts as Aspect may from
time to time designate in writing. All costs incurred in connection with such wire
transfer shall be the responsibility of Philips. Whenever any amount hereunder is
due on a day which is not a day on which banks in Norwood, Massachusetts, U.S.A. or
Boeblingen, Germany, are open for business, such amount shall be paid on the next
Business Day. Amounts hereunder shall be considered to be paid as of the day on
which funds are received by Aspect’s banks. No part of any amount payable to Aspect
hereunder may be reduced due to any counterclaim, set-off, adjustment or other
right which Philips might have or assert against Aspect, any other party or
otherwise.
	 
	 	6.9	 	Limited Warranty.

	 	(a)	 	With respect to the BIS Products, Aspect makes the warranties set
forth in Exhibit D attached hereto and made a part hereof. Under no circumstances
shall the warranties set forth in Exhibit D hereto apply to a BIS Product which
has been customized, modified, damaged or misused by Philips or any third party
in any manner without Aspect’s authorization. Except as provided elsewhere in
this Agreement, Philips’ sole remedy for a non-conforming BIS Product is, at
Aspect’s election, the repair or replacement thereof. THE PROVISIONS OF THE
FOREGOING WARRANTIES ARE IN LIEU OF ANY OTHER WARRANTY, WHETHER EXPRESS OR
IMPLIED, WRITTEN OR ORAL (INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR
A PARTICULAR PURPOSE OR NONINFRINGEMENT).
	 
	 	(b)	 	After expiration of the Warranty Period (as defined in Exhibit D),
Aspect shall undertake repairs of BIS Products or shall provide parts for repairs
by Philips, at reasonable cost to Philips. Both Parties hereby agree on the charge
for such repairs and parts as provided in Exhibits A and G.

	 	6.10	 	Priority of Agreement.
	 
	 	 	 	In the event of any discrepancy between any Purchase Order and this Agreement, the
terms of this Agreement shall govern.
	 
	 	6.11	 	Service and Support.
	 
	 	 	 	Except as otherwise provided in this Agreement, Service and Support provisions from
the 1999 Agreement provided herein as Exhibit G shall continue under this
Agreement. Notwithstanding the foregoing, the Parties shall negotiate in good
faith a new service agreement with a target execution date of March 31, 2009.

 

 

	7.	 	DISTRIBUTION OF BIS SENSORS

	 	7.1	 	Philips has provided to Aspect a list, attached hereto as Exhibit A, Part E —
“Pre-existing Supply Obligation List”, identifying each and every customer with which
Philips has entered into a long-term BIS Sensor purchasing contract that extends beyond
January 1st, 2009 (“Long-Term Sensor Customers”), along with anticipated BIS Sensor
purchase quantities for the remainder of the contract term with respect to each such
Long-Term Sensor Customer.
	 
	 	7.2	 	Philips shall not, and shall ensure that its Affiliates, distributors and
sub-distributors shall not, market or distribute BIS Sensors to customers that are not
Long-Term Sensor Customers and shall not market or distribute BIS Sensors to any Long-Term
Sensor Customer in excess of the applicable quantities set forth in Exhibit A Part E.
For clarity, Philips may sell [**] specified in Exhibit A solely in connection with the
new sale of the Philips BIS Products Solution.
	 
	 	7.3	 	Subject to Section 7.4, Aspect shall sell BIS Sensors to Philips’ customers that are
not Long Term Sensor Customers, either directly by Aspect, through its Affiliates or
through distributors in each country or region.
	 
	 	7.4	 	Aspect will ensure that Philips customers that are not Long-Term Sensor Customers
have an alternative outlet (which may include Aspect or its Affiliates or a third party
distributor) from which to purchase BIS Sensors so that Philips customers are not forced
to purchase BIS Sensors directly from [**]. In the event Aspect does not provide such an
alternative BIS Sensor outlet in a country or region, Aspect (or its local Affiliate) will
grant [**] distribution rights for BIS Sensors in such country or region with terms,
conditions and pricing consistent with those of similar distributors in other countries or
regions offering the same level of marketing, customer, and technical support as the local
Philips Affiliate is prepared to offer. Aspect shall have the right to terminate any such
agreement upon six (6) months notice once Aspect has established an alternative BIS Sensor
outlet for such country or region. Aspect will provide regular updates to Philips
regarding the progress toward the establishment of alternative BIS Sensor outlets.
	 
	 	7.5	 	Philips hereby agrees not to enter into, and to ensure that none of its Affiliates,
distributors or sub-distributors enter into, any new BIS Sensor purchase contracts and not
to renew or extend the term of any BIS Sensor supply contracts with any Long-Term Sensor
Customer.
	 
	 	7.6	 	Aspect agrees to honor Philips BIS Sensor purchase commitments for Long-Term Sensor
Customers by selling directly to the Philips’ central procurement site currently located
at Boeblingen, Germany. Aspect will honor current BIS Sensor pricing for pre-existing
supply contracts to Long-Term Sensor Customers using the price set forth in Exhibit A
Part D in order for Philips to supply BIS Sensors to Long-Term Sensor Customers until the
earlier of the date on which (i) each such contract expires or (ii) the end-user chooses
to buy directly from Aspect.
	 
	 	7.7	 	If any dispute arises between the Parties regarding the status of any contracts for
supply of BIS Sensors to Long-Term Sensor Customers, Aspect will have the
right at its own expense to have an independent auditor review such contracts.

 

 

	 	7.8	 	If any sales by Philips or its Affiliates, distributors or sub-distributors of BIS
Sensors are made to any customer in contravention of Sections 7.2 and/or 7.5, Philips will
cease such sales and Philips will retroactively pay Aspect an additional $[**] previously
sold to customers in contravention of Sections 7.2 and/or 7.5. In addition, Philips shall
reimburse Aspect for the cost of any audit that confirmed the existence of any such sales.
	 
	 	7.9	 	Compensation for US-Based BIS Product Sales.

	 	7.9.1	 	Installed Base Payments. Subject to Section 7.11.1, for each Aspect
BIS Sensor sold by Aspect to Philips US customers for use with Philips BIS Products
that were sold prior to the Effective Date under the 1999 Agreement, Aspect shall pay
Philips [**] billed by Aspect for such Aspect BIS Sensors (“Installed Base Payments”).
	 
	 	7.9.2	 	US Discount Program. Aspect will provide a discount to Philips of
$[**] for each BIS Product purchased by Philips or its Affiliates, distributors or
sub-distributors for sale to end user customers in the US after the Effective Date.
Said discount shall be applied at time of invoicing of each BIS Product by Aspect.
	 
	 	7.9.3	 	The purpose of the payments under sections 7.9.1 and 7.9.2 is to compensate
Philips at a fair market value amount for the promotion, sales and servicing by Philips
of the BIS Products and to ensure equitable access for health care providers to all
technologies. If any court opinion, federal agency ruling, federal or state
enforcement action or interpretation (including any settlement) or DHHS Office of
Inspector General advisory opinion alters the interpretation or application of the
federal anti-kickback laws such that, in the written opinion of legal counsel for
either Party, the compensation payments set forth in this Section 7.9 may no longer be
compliant with such laws, the Parties agree to engage in good faith negotiations to
revise the compensation provisions to the extent necessary to remain compliant with the
federal anti-kickback laws, including potentially restructuring or eliminating payments
hereunder. If the Parties are unable to reach agreement on the terms of the revision,
the dispute shall be resolved in accordance with Section 13.4 herein.

	 	7.10	 	Compensation for Sales of BIS Products Outside the United States.

	 	7.10.1	 	For the year 2008, Aspect shall pay to Philips a fixed commission of $[**].
	 
	 	7.10.2	 	Should BIS Sensor volumes sold to Philips exceed [**] units from July 1st, 2008 to
December 31st 2008, the $[**] compensation paid by Aspect to Philips pursuant to
Section 7.10.1 will be reduced by $[**] for each BIS Sensor exceeding [**] units.
	 
	 	7.10.3	 	Outside US Discount Program. Aspect will provide a discount to Philips of $[**] for
each BIS Product purchased by Philips or its Affiliates, distributors or sub-

 

 

	 	 	 	distributors for sale to end user customers outside the US after the Effective
Date. Said discount shall be applied at time of invoicing of each BIS Product by
Aspect.

	 	7.10.4	 	Philips will have the right to hire (at its own expense) an independent auditor to
verify both the commission and the discount calculations.

	 	7.11	 	Additional Compensation Details.

	 	7.11.1	 	With respect to Installed Base Payments within the United States, BIS Sensor
commissions will be paid for a period of [**] full years for each Philips-sold BIS
Product from the date of installation at the customer site, which may have been prior
to the Effective Date. Aspect shall pay commissions due Philips on a [**] basis. With
such [**] payments, Aspect shall provide to Philips a list of Philips United States
customers to which such sales were made, the number of BIS Sensors sold in that [**],
and the net revenue billed for the sale of the BIS Sensors by Aspect.
	 
	 	7.11.2	 	This [**] payment shall be provided to Philips no later than [**] days following the
end of each [**]. In the event that Aspect’s standalone BIS monitors, the BIS modules
and/or the BIS or BISx systems of or sold by other original equipment manufacturers
have also been installed at such sites/regions in addition to Philips BIS Products,
Philips will be entitled to a commission only on BIS Sensor sales intended for use with
Philips BIS Products. A pro rata determination will be based on the total number of BIS
units of different types installed at such locations during the period according to
Aspect’s installed base records. Such installed base records shall be subject to the
same [**] year period as that provided for Philips-sold BIS Products for the purposes
of calculating commissions according to this Section 7. To facilitate such
calculations, Philips will be responsible for providing Aspect with the documentation
required in Section 6.7, and Aspect shall be responsible for providing Philips with
accurate information regarding the total number of non-Philips units which have been
installed, and are in use, at such sites/regions. The information on total installed
BIS systems at Philips accounts is auditable by an independent auditor at Philips’
expense, provided that such independent auditor (i) is bound by obligations of
confidentiality and non-use at least as protective of Aspect’s records as the
provisions of Section 8 are with respect to Proprietary Information, and (ii) shall
disclose to Philips only the percentage of total installed BIS systems that are
installed at Philips accounts. In the event such audit identifies an underpayment by
Aspect of at least five percent (5%), Aspect shall reimburse Philips for the cost of
such audit. The information underlying the reports provided by Philips pursuant to
Section 6.7 is auditable by an independent auditor at Aspect’s expense, provided that
such independent auditor (a) is bound by obligations of confidentiality and non-use at
least as protective of Philips’ records as the provisions of Section 8 are with respect
to Proprietary Information, and (b) shall disclose to Aspect only the information
necessary to document any discrepancies

 

 

	 	 	 	in the reports. In the event such audit identifies an overpayment by Aspect of at
least five percent (5%), Philips shall reimburse Aspect for the cost of such audit.

	8.	 	CONFIDENTIAL INFORMATION

	 	8.1	 	Agreement.
	 
	 	 	 	This Agreement and all documents, drawings, manuals and other materials related
thereto and transmitted between the Parties shall be treated as Proprietary
Information (as defined in Section 8.2) by the Parties and their employees and such
information shall not be disclosed to any third party except as provided by this
Agreement.
	 
	 	8.2	 	Confidentiality Obligations.
	 
	 	 	 	Each Party (the “disclosing Party”) has a proprietary interest in information which
it discloses to the other Party (the “receiving Party”), whether in connection with
this Agreement or otherwise, which is (a) a trade secret, confidential or
proprietary information, (b) not publicly known, and (c) annotated by a legend,
stamp or other written identification as confidential or proprietary information,
or if disclosed orally, is identified as confidential or proprietary by a written
instrument within 30 days of such disclosure (referred to herein as “Proprietary
Information”). The receiving Party shall disclose the Proprietary Information of
the disclosing Party only to those of its agents and employees to whom it is
necessary in order properly to carry out their duties as limited by the terms and
conditions hereof. Both during and after the Agreement Term, all disclosures by the
receiving Party to its agents and employees shall be held in strict confidence by
such agents and employees. During and after the Agreement Term, the receiving
Party, its agents and employees shall not use the Proprietary Information for any
purpose other than in connection with discharging its duties pursuant to this
Agreement. The receiving Party shall, at its expense, return to the disclosing
Party the Proprietary Information of the disclosing Party or certify its
destruction as soon as practicable after the termination or expiration of this
Agreement but in no event later than thirty (30) days after such expiration or
termination. During the Agreement Term and thereafter, all such Proprietary
Information shall remain the exclusive property of the disclosing Party. Each Party
shall ensure that any consultants or subcontractors that it may engage in
connection with its obligations under this Agreement (including Affiliates of the
receiving Party) are bound by obligations of confidentiality and nonuse with
respect to the Proprietary Information of the other Party at least as protective as
those set forth in this Section 8.
	 
	 	8.3	 	Exceptions.
	 
	 	 	 	Notwithstanding anything contained in this Agreement to the contrary, the receiving
Party shall not be liable for a disclosure of the Proprietary Information of the
disclosing Party if the information so disclosed: (a) was in the public domain at
the time of disclosure without breach of this Agreement; or (b) was known to or
contained in the records of the receiving Party from a source other than the
disclosing Party at the time of disclosure by the disclosing Party to the receiving
Party and can be so demonstrated; or (c) becomes known to the receiving Party from
a source other than the disclosing Party without breach of

 

 

	 	this Agreement by the receiving Party and can be so demonstrated; or (d) was
disclosed pursuant to court order or as otherwise compelled by law, provided that
the receiving Party gives the disclosing Party prior written notice of such
compelled disclosure, if permitted, and assists the disclosing Party in its
reasonable efforts to prevent or limit such disclosure.

	9.	 	QUALITY ASSURANCE / REGULATORY MATTERS

	 	9.1	 	Certification Status.
	 
	 	 	 	Both Parties agree to maintain, as applicable, ISO13485, CAN/CSA-ISO 13485:03
certified by a Health Canada recognized Registrar, European directive 93/42/EEC
Annex II (“MDD AX-II”) certification status and compliance with the U.S. Food and
Drug Administration’s (“FDA”) Quality System Regulation (“QSR”), the European
Medical Device Directive (“MDD”), and other appropriate regulations pertinent to
the development, manufacturing and marketing of medical products similar to the BIS
Products.
	 
	 	9.2	 	Regulatory Responsibility — Aspect.
	 
	 	 	 	In particular, Aspect shall be responsible, with respect to BIS Products, for
achieving and maintaining FDA 510(k) clearance, Canadian Medical Device Licence,
and compliance with the EU Council Directive 93/42/EEC (DoC).
	 
	 	9.3	 	Regulatory Requirements — Philips.
	 
	 	 	 	Philips shall assume the regulatory responsibility to achieve regulatory
approvals/registrations for the combination of the Aspect Products and Philips
Patient Monitors. Aspect shall provide commercially reasonable support to Philips
as required in the process of obtaining regulatory approvals by making available to
Philips any required information, data, certificates, or technical files in the
requested formats as requested by the regulatory authorities.
	 
	 	9.4	 	Product Complaints and Incident Reporting.
	 
	 	 	 	Philips and Aspect shall inform each other (in writing) quarterly of any and all
customer complaints that have come to their attention during the prior quarter
regarding the Aspect Products or BIS Sensors that were used in conjunction with a
Philips Patient Monitor and relating to Aspect technology. Both Parties will
cooperate and use reasonable efforts to resolve such customer complaints. Closure
of any such customer complaints relating to the Philips BIS Patient Monitor
Solution will occur when Philips notifies Aspect that the problem is resolved,
except that closure of any such customer complaint relating solely to BIS Products
or BIS Sensors will occur when Aspect notifies Philips that the problem is
resolved.
	 
	 	 	 	Philips and Aspect shall inform each other in writing of all incidents relating to
Aspect Products within 48 hours of making a determination that such event requires
reporting under any applicable regulatory or other governmental reporting
requirements, including without limitation incidents involving death or serious
injury, malfunctions that, if recurrent, may cause or contribute to death or
serious injury or other material quality problems or concerns; provided, however,
for the purposes of clarity, if such reportable event involves a third party
product

 

 

	 	 	 	into which the Aspect Product has been incorporated, but the cause of reportable
incident was some other aspect or attribute of such third party product, then the
notification requirement in this paragraph shall not apply. Aspect will be
responsible for reporting such incidents to the appropriate regulatory authority
for the Aspect Products. Philips will be responsible for reporting such incidents
to the appropriate regulatory authority for the Philips BIS Products Solution
(other than the BIS Products) or Philips Patient Monitor. Both Parties shall fully
cooperate with each other as may be necessary to comply with any reporting
obligations regarding such incidents or quality concerns. If FDA or other
authorities contact either Party to inquire about or investigate the Aspect
Products sold to Philips under this Agreement, the contacted Party, unless required
to maintain confidentiality by such authorities, shall inform the other Party
immediately thereof. The Parties shall cooperate closely to clear any regulatory
issues or potential regulatory issues promptly.
	 
	 	9.5	 	Traceability.
	 
	 	 	 	Philips agrees to maintain traceability through Aspect serial number and/or lot
code for all Aspect Products shipped to Philips.

	10.	 	COMMUNICATION
	 
	 	 	All communication in conjunction with this Agreement shall be directed to the appropriate
person and address listed in Exhibit C (Contact Persons / Addresses).

	11.	 	INDEMNIFICATIONS

	 	11.1	 	In Favor of Aspect.

(A) Philips hereby agrees to indemnify and hold harmless Aspect, its Affiliates and all
officers, directors, employees and agents thereof from all liabilities, claims, damages,
losses, costs, expenses, demands, suits and actions (including without limitation attorneys’
fees, expenses and settlement costs) (collectively, “Damages”), arising out of personal
injuries and/or tangible property damages, to the extent (a) caused by a defect in the Philips
Patient Monitor or in the design of the Monitor Cable, (b) relating to the failure of Philips
to incorporate the Aspect Products with Philips Patient Monitors in accordance with the
Technical Information provided by Aspect hereunder, or (c) relating to any delay or failure by
Philips to implement any modification or improvement set forth in Section 3.3 (Required
Changes).

(B) Philips hereby agrees to indemnify and hold harmless Aspect, its Affiliates and all
officers, directors, employees and agents thereof from all Damages arising out of any
third-party infringement claim to the extent the infringement is caused solely by the Philips
Patient Monitor or compliance with Philips’ specifications for design of the Monitor Cable
provided such specifications cannot be implemented in a commercially reasonable non-infringing
manner.

	 	11.2	 	In Favor of Philips.

(A) Aspect hereby agrees to indemnify and hold harmless Philips, its Affiliates and

 

 

all
officers, directors, employees and agents thereof from all Damages, arising out of personal
injuries and/or tangible property damages, to the extent (a) caused by a defect in the
manufacture of the Monitor Cable or a defect in any other Aspect Product or (b) relating to any
inaccuracy in the Technical Information provided by Aspect hereunder with respect to the Aspect
Products (excluding the Monitor Cable).

(B) Aspect hereby agrees to indemnify and hold harmless Philips, its Affiliates and all
officers, directors, employees and agents thereof from all Damages arising out of any claim
that: (a) the Licensed Technology infringes on the intellectual property rights of third
parties, provided that neither Philips nor its Affiliates own such intellectual property; or
(b) use of the Aspect Trademarks in accordance with Section 2.4 above infringes on the
trademark, service mark or trade name rights of third parties, provided that neither Philips
nor its Affiliates own such trademark, service mark or trade name; further provided, however
that:

Aspect shall have no obligation for any claim of infringement arising from:

	 	(i)	 	any combination by Philips of the Aspect Products with
any other product not supplied or approved in writing by Aspect where such
infringement would not have occurred but for such combination;
	 
	 	(ii)	 	the adaptation or modification of the Aspect Products not
performed or not authorized by Aspect, where such infringement would not
have occurred but for such adaptation or modification;
	 
	 	(iii)	 	the misuse of the Aspect Products or the use of any
Aspect Product in an application for which it was not designed by Aspect,
where such infringement would not have occurred but for such use or misuse;
	 
	 	(iv)	 	compliance with Philips’ specifications for design of the
Monitor Cable provided such specifications cannot be implemented in a
commercially reasonable non-infringing manner; or
	 
	 	(v)	 	infringement to the extent solely caused by a Philips
Patient Monitor.

Notwithstanding anything to the contrary, nothing in this Agreement restricts Philips from
asserting whatever intellectual property rights it may have in the Licensed Technology against
Aspect.

	 	11.2.1	 	In the event that any of the Licensed Technology is held in a suit or proceeding
to infringe any intellectual property rights of a third party, and the use of any
of the Licensed Technology is enjoined or Aspect reasonably believes that it is
likely to be found to infringe or likely to be enjoined, Aspect shall, at its sole
cost and expense, either (i) procure for Philips the right to continue
manufacturing, using and selling the Licensed Technology subject to the terms of
this Agreement, or (ii) replace the Licensed Technology with a non-infringing
alternative of equivalent functionality. If neither (i) nor (ii) are practicable,
either Party may terminate this Agreement, effective immediately, upon giving the
other Party written notice.

 

 

	 	11.2.2	 	This Section 11.2 constitutes Philips’ exclusive remedy in the event that any of
the Licensed Technology and/or the Aspect Trademarks infringe on the intellectual
property rights of third parties.

	 	11.3	 	Indemnification Procedures.
	 
	 	 	 	In the event that any person intends to claim indemnification pursuant to this
Agreement, (an “Indemnitee”), it shall promptly notify the indemnifying Party (the
“Indemnitor”) in writing of such alleged liability, provided that the failure to
promptly notify the Indemnitor shall not relieve the Indemnitor of any obligation
under this Agreement except to the extent such failure to provide prompt notice
adversely impairs the Indemnitor’s ability to defend against the claim, suit or
proceeding.

	 	11.3.1	 	The Indemnitor shall have the sole right to control the defense and settlement
thereof, provided, that (i) the Indemnitor may not consent to imposition of any
obligation or restriction on, or the admission of any wrongdoing on the part of,
the Indemnitee in any settlement unless mutually agreed among Aspect and Philips,
(ii) Indemnitor shall keep Indemnitee fully informed and permit the Indemnitee to
participate (at Indemnitee’s expense) as the Indemnitee may reasonably request, and
(iii) Indemnitee may, without affecting its right to indemnity hereunder, defend
and settle any such claim, suit or proceeding if Indemnitor declines to defend
against such claim, suit or proceeding or files for bankruptcy. The Indemnitee
shall reasonably cooperate with the Indemnitor and its legal representatives in the
investigation of any action, claim or liability covered by this Agreement, at the
expense of the Indemnitor.
	 
	 	11.3.2	 	The Indemnitee shall not, except at its own cost, voluntarily make any payment or
incur any expense with respect to any claim or suit without the prior written
consent of Indemnitor, which Indemnitor shall not be required to give, provided
that the Indemnitee may, without affecting its right to indemnity hereunder, defend
and settle any such claim, suit or proceeding if the Indemnitor declines to take
responsibility or files for bankruptcy.

	 	11.4	 	Partial Indemnification.
	 
	 	 	 	In the event a claim is based partially on an indemnified claim described in
Sections 11.1 and/or 11.2 above and partially on a non-indemnified claim, or is
based partially on a claim described in Section 11.1 above and partially on a claim
described in Section 11.2 above, any Damages incurred in connection with such
claims are to be apportioned between the Parties in accordance with the degree of
cause attributable to each Party as determined under Section 11.5 below.
	 
	 	11.5	 	Determination of Indemnification Obligations. The extent of any
indemnification obligations set forth in this Section 11 shall be determined according to
the degree of cause attributable to each Party as determined in one of the following
manners:

 

 

	 	(a)	 	by the holding of a court of competent jurisdiction in a
proceeding in which both Parties had the opportunity to be a party; or
	 
	 	(b)	 	by the terms of any settlement agreement mutually agreed by
the Parties; or
	 
	 	(c)	 	in accordance with the procedures set forth in Section 13.4.

	12.	 	TERMINATION OR EXPIRATION

	 	12.1	 	Term and Renewal.
	 
	 	 	 	Unless it is terminated earlier pursuant to this Section 12, the initial term of
this Agreement shall commence on the Effective Date and shall continue for a period
of three (3) years (“Initial Term”). After the Initial Term this Agreement shall
be automatically extended for a maximum of two successive 1 (one) year periods
unless either Party provides written notice to the other Party of its desire not to
renew this Agreement at least 3 months prior to the applicable anniversary date of
this Agreement. The term of this Agreement may be renewed by mutual written
agreement of the Parties prior to the expiration of the Initial Term.
	 
	 	12.2	 	Termination for Cause.
	 
	 	 	 	Upon the occurrence of a material breach or default as to any obligation hereunder
by either Party and the failure of the breaching Party to cure within thirty (30)
days after receiving written notice thereof from the non-breaching Party of such
material breach or default, this Agreement may be terminated by the non-breaching
Party by giving written notice of termination to the breaching Party after such
thirty (30) day period, such termination being immediately effective upon the
giving of such notice of termination.
	 
	 	12.3	 	After Termination or Expiration.
	 
	 	 	 	The Parties agree that, once this Agreement is terminated or expires, Philips shall
immediately cease:

(a) any use or practice of the Licensed Technology; and

(b) any use or sale of the Aspect Products; provided, however
that:

	 	(i)	 	Philips shall have the right to sell Aspect Products which
are in Philips’ possession at the time of such termination or expiration for
a period of six (6) months after such termination or expiration;
	 
	 	(ii)	 	Aspect or any third party designated by Aspect shall sell
to Philips the parts necessary to repair the BIS Products and shall grant to
Philips the right to repair BIS Products, for a period reasonably deemed that
BIS Products are used by the customers, but no more than for a period of 7
years; and
	 
	 	(iii)	 	Aspect or any third party designated by Aspect shall
continue to supply end-users for no more than 7 years with BIS Sensors to use
with BIS Products.

	 	12.4	 	Payment Obligations Continue.

	 	 	 	Upon termination or expiration of this Agreement, nothing shall be construed to

 

 

	 	 	 	release Aspect from its BIS Sensor commission payment obligations provided in
Section 7 herein with respect to BIS Products sold by Philips prior to the date of
such termination or expiration or in accordance with Section 12.3(b), or Philips
from its obligations to pay Aspect any and all amounts accrued but unpaid pursuant
to Section 6 above prior to the date of such termination or expiration.

	 	12.5	 	No Damages for Termination.
	 
	 	 	 	The Parties agree that if either Party terminates this Agreement pursuant to
Section 12.2, then the terminating Party shall not be liable for damages or
injuries suffered by the other Party solely as a result of that termination, unless
otherwise expressly provided herein.

	13.	 	MISCELLANEOUS

	 	13.1	 	LIMITATION ON LIABILITY.

	 	(a)	 	EACH PARTY’S LIABILITY TO THE OTHER PARTY ARISING OUT OF THE
MANUFACTURE, SALE OR SUPPLYING OF PRODUCTS OR THEIR USE, OR DISPOSITION OF THEIR
OBLIGATIONS OR RESPONSIBILITIES UNDER THIS AGREEMENT, WHETHER BASED UPON
WARRANTY, CONTRACT, TORT OR OTHERWISE, SHALL NOT EXCEED THE GREATER OF (A) FIVE
MILLION DOLLARS ($5,000,000.00) OR (B) THE SUM OF (i) THE TOTAL ACTUAL PURCHASE
PRICE PAID OR PAYABLE BY PHILIPS FOR ALL ASPECT PRODUCTS PURCHASED HEREUNDER AND
(ii) ALL AMOUNTS PAID OR PAYABLE BY PHILIPS TO ASPECT FOR SERVICE AND SUPPORT
PROVIDED UNDER THIS AGREEMENT.
	 
	 	(b)	 	IN NO EVENT SHALL EITHER PARTY BE LIABLE TO THE OTHER PARTY FOR
SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR OTHER INDIRECT DAMAGES (INCLUDING, BUT NOT
LIMITED TO, LOSS OF PROFITS, LOSS OF DATA OR LOSS OF USE DAMAGES) ARISING OUT OF
THE MANUFACTURE, SALE OR SUPPLYING OF PRODUCTS OR THE OBLIGATIONS OR
RESPONSIBILITIES UNDER THIS AGREEMENT.
	 
	 	(c)	 	THE LIMITATIONS IN THIS SECTION 13.1 WILL NOT APPLY TO CLAIMS FOR
DAMAGES FOR BODILY INJURY (INCLUDING DEATH) AND DAMAGE TO TANGIBLE PERSONAL
PROPERTY FOR WHICH A PARTY IS LEGALLY LIABLE AND/OR A PARTY’S INDEMNIFICATION
OBLIGATIONS CONTAINED IN THIS AGREEMENT.

	 	13.2	 	Assignment.
	 
	 	 	 	This Agreement and the rights and obligations hereunder may not be assigned,
delegated or transferred by either Party without the prior written consent of the
other Party; provided, however that the other Party’s consent shall not be required
with respect to any assignment, delegation or transfer by a Party to (i) an
Affiliate of such Party; (ii) the purchaser of all or substantially all of the (A)
assets related to this Agreement or (B) stock of such Party, through merger,

 

 

	 	 	 	consolidation or otherwise; or (iii) Aspect’s assignment to any third party(ies) of
its right to collect payment hereunder. To the extent permitted by this Agreement,
this Agreement shall be binding upon and inure to the benefit of the permitted
successors and assigns of both Parties.

	 	13.3	 	Governing Law.
	 
	 	 	 	This Agreement shall be construed and governed according to, and any judicial
proceedings shall be conducted in accordance with the laws of the Commonwealth of
Massachusetts, U.S.A., excluding its conflicts of laws principles.
	 
	 	13.4	 	Dispute Resolution.

	 	(a)	 	Any dispute, controversy or claim arising out of or relating to
this Agreement or to a breach hereof, including its interpretation, performance
or termination, shall be resolved by good faith negotiations between the Parties,
who in all cases shall endeavor to resolve all disputes promptly on mutually
acceptable, fair and reasonable terms.
	 
	 	(b)	 	If after twenty (20) Business Days the Parties in good faith fail
to resolve any such dispute, the dispute will be escalated for resolution by the
Vice President of Emerging Technologies (or designee) for Aspect and the Vice
President and General Manager of its Measurements and Monitoring business unit
(or designee) for Philips. If such negotiations do not reach a resolution within
thirty (30) days after such escalation, either Party shall thereafter have the
right to institute judicial proceedings to resolve such dispute, controversy, or
claim.

	 	13.5	 	Entire Agreement.
	 
	 	 	 	Except as expressly set forth herein, this Agreement supersedes and cancels any
previous agreements or understandings, whether oral, written or implied, heretofore
in effect, including the 1999 Agreement, and sets forth the entire agreement
between Aspect and Philips and its Affiliates with respect to the Aspect Products
and the BIS Products. As of the Effective Date, and notwithstanding any
requirements of notice prior to termination, the Parties agree that any such
previous agreements or understandings shall be terminated, and effective only for
determining the Parties’ respective rights and obligations with respect to any
products or services ordered (except for any compensation payments from Aspect to
Philips, which shall be governed by Sections 7.9 and 7.10 of this Agreement and not
by any provision of the 1999 Agreement), or information exchanged or obtained,
under such agreements or understandings, provided, however, that any information
subject to any duties of nondisclosure or nonuse under any agreement superseded by
this Agreement pursuant to this Section 13.5 shall be deemed “Proprietary
Information” subject to the obligations set forth in Section 8 hereof. No
modification or change may be made in this Agreement except by written instrument
duly signed by a duly authorized representative of each Party.
	 
	 	13.6	 	Notices.
	 
	 	 	 	All notices given under this Agreement shall be in writing and shall be addressed
to the Parties at their respective addresses and email addresses, and to the
attention of the individuals set forth in Exhibit C. Either Party may change

 

 

	 	 	 	its address, telecopy number and contact person for purposes of this Agreement by
giving the other Party written notice of its new address, email address or contact
person. Any such notice if given or made by registered or recorded delivery
international air mail letter shall be deemed to have been received on the date
actually if made by email transmission shall be deemed to have been received at the
time of dispatch, unless such date of deemed receipt is not a day on which banks in
the receiving Party’s home city are open for business, in which case the date of
deemed receipt shall be the next day on which banks in the receiving Party’s home
city are open for business.

	 	13.7	 	Waivers.
	 
	 	 	 	None of the conditions or provisions of this Agreement shall be held to have been
waived by any act or knowledge on the part of either Party, except by an instrument
in writing signed by a duly authorized officer or representative of such Party.
Further, the waiver by either Party of any right hereunder or the failure to
enforce at any time any of the provisions of this Agreement, or any rights with
respect thereto, shall not be deemed to be a waiver of any other rights hereunder
or any breach or failure of performance of the other Party.
	 
	 	13.8	 	Responsibility for Taxes.
	 
	 	 	 	Taxes now or hereafter imposed with respect to the transactions contemplated
hereunder shall be the responsibility of Philips, and if paid or required to be
paid by Aspect, the amount thereof shall be added to and become a part of the
amounts payable by Philips hereunder.
	 
	 	13.9	 	Severability.
	 
	 	 	 	If, under applicable law or regulation, any provision of this Agreement is invalid
or unenforceable or directly or indirectly affects the validity of any other
material provision(s) of this Agreement (“Severed Clause”), it is mutually agreed
that this Agreement shall endure except for the Severed Clause. The Parties shall
consult and use their best efforts to agree upon a valid and enforceable provision
which shall be a reasonable substitute for such Severed Clause in light of the
intent of this Agreement.
	 
	 	13.10	 	Counterparts.
	 
	 	 	 	This Agreement may be executed in one or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one and the same
instrument.
	 
	 	13.11	 	Relationship of the Parties.

	 	(a)	 	The relationship between Aspect and Philips shall not be construed to
be that of employer and employee, or to constitute a partnership, joint venture or
agency of any kind. Neither Party shall have any right to enter into any contracts
or commitments in the name of, or on behalf of, the other Party, or to bind the
other Party in any respect whatsoever.
	 
	 	(b)	 	Philips shall not obligate or purport to obligate Aspect by issuing or
making any affirmations, representations, warranties or guarantees with respect to
BIS Products to any third party, other than the warranties described in Exhibit D
hereto.

 

 

	 	(c)	 	Each Party may perform its obligations and duties hereunder through one
or more of its Affiliates, and Affiliates of the Parties are expressly granted
certain rights herein; provided, that each such Affiliate shall be bound by the
corresponding obligations of such Party and the relevant Party shall remain liable
hereunder for the performance of all their respective obligations hereunder.

	 	13.12	 	Survival of Contents.
	 
	 	 	 	Notwithstanding anything else in this Agreement to the contrary, the Parties agree
that Sections 2.1(d)-(g), 2.3, 2.4, 2.6, 2.7, 2.9, 3.3, 4, 6.9, 6.10, 7.7, 7.8, 8
(for seven (7) years, except perpetually for Software and Technical Information),
9.4 (second paragraph only), 9.5, 10, 11, 12.3, 12.4, 12.5 and 13 shall survive the
termination or expiration of this Agreement, as the case may be.
	 
	 	13.13	 	Compliance With Laws.
	 
	 	 	 	Each of Philips and Aspect covenants that all of its activities under or pursuant
to this Agreement shall comply with all applicable laws, rules and regulations.
Philips, with Aspects’ support and all necessary assistance, shall be responsible
for obtaining all licenses, permits and approvals which are necessary or advisable
for sales of BIS Products in all jurisdictions and for the performance of its
duties hereunder.
	 
	 	13.14	 	Headings.
	 
	 	 	 	Any headings contained herein are for directory purposes only, do not constitute a
part of this Agreement, and shall not be employed in interpreting this Agreement.
	 
	 	13.15	 	Language.
	 
	 	 	 	All written material, correspondence, Technical Information, notices and oral
assistance supplied by either Party hereunder shall be in the English language.
	 
	 	13.16	 	Exhibits.
	 
	 	 	 	The following Exhibits shall be part of this Agreement:

	 	 	 	 	 
	 

	 	EXHIBIT A
	 	Aspect Products and Purchase Prices
	 
	 	 	 	 
	 

	 	EXHIBIT B
	 	Specifications: BIS Products
	 
	 	 	 	 
	 

	 	EXHIBIT C
	 	Contact Persons / Addresses
	 
	 	 	 	 
	 

	 	EXHIBIT D
	 	Warranty
	 
	 	 	 	 
	 

	 	EXHIBIT E
	 	Aspect Trademarks
	 
	 	 	 	 
	 

	 	EXHIBIT F
	 	Philips Trademarks
	 
	 	 	 	 
	 

	 	EXHIBIT G
	 	Service, Support and Repair

 

 

     IN WITNESS WHEREOF, the Parties hereto have signed this Agreement under seal.

	 	 	 
	ASPECT MEDICAL SYSTEMS INC.

	 	Philips Medizin Systeme Böblingen GmbH
	 
	 	 
	By: /s/ J. Neal Armstrong          

	 	By:  /s/ W. Haas               
	 
	 	 
	Typed Name: J. Neal Armstrong          

	 	Typed Name: W. Haas               
	 
	 	 
	Title: CFO          

	 	Title: VP, GM
	 
	 	 
	Date: 4/24/09          

	 	Date: 14-Apr-2009               
	 
	 	 
	 

	 	Philips Medizin Systeme Böblingen GmbH
	 
	 	 
	 

	 	By: /s/ Dreher               
	 
	 	 
	 

	 	Typed Name: Dreher               
	 
	 	 
	 

	 	Title: Managing Director               
	 
	 	 
	 

	 	Date: 14-Apr-2009               

 

 

EXHIBIT A

ASPECT PRODUCTS AND PURCHASE PRICES

A) BIS Products:

List price for the BIS Products: $[**]. Volume discounts are available as follows:

	 	 	 	 	 	 	 
	Part #	 	Description	 	Aspect List Price	 	Philips Price
	 
	186-0195-PH

	 	BISx Kit
	 	$[**]
	 	See Below

	 	 	 
	As of Effective Date
	Volume	 	Pricing (1)
	0 — 1500
	 	$[**]
	1501 — 2500
	 	$[**]
	2501 — 3500
	 	$[**]
	>3500
	 	$[**]

For the purpose of calculating the volume discount for a given calendar year, all BIS Products
sold as reported by Philips according to Section 6.7 above during that calendar year (excluding
BIS Products that are provided free of charge) (“Reported Sales”) will be included in the total
volume discount calculation.

The initial pricing for a given calendar year is based on the total of BIS Products Reported
Sales in the prior calendar year. Philips will maintain the previous year pricing as long as
they maintain the Reported Sales volume levels required for that pricing. For example, if there
were Reported Sales of [**].

If a higher volume level of BIS Products is achieved during a given calendar year, the price on
purchases made after achieving the higher volume level will reflect the price associated with
the appropriate volume level achieved. All price adjustments are proactive and no credit will
apply retroactively to units purchased prior to achieving the volume break point. For example,
if midway through year 1, [**] are reported, the price on [**] will reflect the next volume
break. Achieving this higher volume level will also reduce the initial pricing for the
following year.

The initial volume discount will be calculated at the Effective Date based on the volume of BIS
Products previously purchased by Philips during the previous 12 month period under the 1999
Agreement. The discounts according to sections 7.9.2 and 7.10.3 shall be applied by Aspect in
addition to the volume discounts described above.

(1) Volume pricing before discount program provided in 7.9.2 and 7.10.3

B) BIS SENSORS

	 	•	 	For the purpose of this Agreement, Aspect will include [**] with each BIS Product
shipped to Philips.

	 	o	 	Price for the [**] will be $[**].

	 	•	 	Philips may also order [**] solely for resale to a customer together with the sale of
any new BIS Product (the “K-Options”):

 

 

	 		 	#K20: 50x BIS Quatro sensors — price is $[**]
	 
	 		 	#K21: 100x BIS Semi-reusable sensors — price is $[**]

C) SERVICE PARTS:

	 	 	 	 	 
	Part #	 	Description 	 	Philips Price
	186-0199-PH

	 	Philips BISx Kit (Refurbished) / Exchange
	 	$[**]
	186-0201-PH

	 	Philips BISx Host Cable Kit (Replacement)
	 	$[**]
	186-0202-PH

	 	Philips BISx BulkHead Kit (Replacement)
	 	[**]
	186-0133

	 	Philips BIS Sensor Simulator
	 	$[**]
	186-0131

	 	Philips PIC+ Cable (replacement)
	 	$[**]

D) PRE-EXISTING SENSOR PRICING AND QUANTITIES

As described in Section 7, “Distribution of BIS Sensors”, Philips will be allowed to order the
following quantities of BIS Sensors to meet pre-existing customer commitments:

Prices for the BIS Sensor quantities purchased pursuant to Section 7.6 will be $[**].

 

 

E) Pre-existing Supply Obligation List

     [**]

 

EXHIBIT B

SPECIFICATIONS: BIS Products

BISx is a device that acquires up to two channels of EEG and computes BIS and other EEG parameters,
uniting the functionality of the existing Aspect BIS Engine and DSC-XP. BISx is designed to mate
with Aspect’s XP platform 1 or 2 channel sensors. BISx has no display or user interface. It plugs
into a host monitor system for display of EEG and processed parameters. BISx is designed for use
wherever sedative drugs are administered, including but not limited to the following environments:
Operating rooms, Intensive Care Units, Procedural Sedation, and Clinical Research areas.

The standard BISx acquires EEG via single channel or two channel referential XP platform sensors
and XP compatible sensors. The inputs are protected against damage from electro-static discharge
(ESD), a direct hit from an electrocautery device, and defibrillation of the patient to which it is
attached. The BISx recovers from large signal saturation quickly. The BISx is resistant to
electro-surgical (ESU) interference.

The BISx is designed to be placed near the patient’s head. It is unobtrusive and conveniently
handled. It is sealed so as not to allow liquids to enter when splashed. The enclosure is not
painted, but rather is of materials that are a solid color throughout. The BISx includes a
convenient method for attaching and de-attaching the enclosure to surgical draperies, sheets, or an
IV pole.

The BISx is attached to the host monitoring system via a 9-foot monitor cable. The wire is narrow
and highly flexible. The monitor connection is integral to the enclosure (no pigtail), and may
require the use of tools for detachment from the device for service or replacement. The enclosure
is sealed against liquid ingress only when the monitor cable is attached. The connector on the host
monitor end is chosen in collaboration with the OEM host partner company. There are no adjustable
parts inside the BISx. The cables may be replaced without opening the enclosure.

 

 

The BISx connects to a sensor via the Aspect PIC Plus (Aspect part number 186-0107). The PIC Plus
is approximately 48 inches long. The PIC Plus connection is integral to the enclosure (no
pigtail), and can be detached from the device for service or replacement without the use of tools.
The enclosure is sealed against liquid ingress even when the PIC is detached.

Each BISx is given a unique serial identifier, allowing for electronic identification and tracking
of every device.

BISx can be connected and disconnected to an already powered up host monitor. The host monitor
should automatically detect its presence and configure it accordingly.

The BISx is a High Power, USB Powered Device which adheres to the power requirements of the USB 2.0
specification. The BISx requires 5 Vdc +/- 5% to operate and may draw up to 500 mA.

PHYSICAL SPECIFICATIONS:

BISx

Size: 95.3 mm (3.75”) diameter x 63.5 mm (2.5”) height

Weight: 227g (8.0 oz) without cables

456g (1.0 lb) with cables (Estimated)

BISx Integral Cables

Monitor Cable: 2.74m (9ft)

Patient Interface Cable (PIC+): 1.4m (4.5 ft)

SAFETY SPECIFICATIONS:

	•	 	The BISx complies with the essential requirements of the Medical Device Directive
93/42/EEC, as well as IEC 60601-1 and IEC 60601-2-26.
	 
	•	 	It is a Type BF applied part. It has internal optical coupling and an isolation transformer
for patient isolation.
	 
	•	 	It is protected against damage from defibrillation as long as the sensor is not located
between the defibrillator pads and is resistant to artifact from electrosurgery.
	 
	•	 	United States federal law restricts this device to sale by or on the order of a physician.
	 
	•	 	BISx and cables are latex free.

ENVIRONMENTAL SPECIFICATIONS:

Liquid Ingress Rating

IEC 529 IPX4

Temperature Range

Operating: 0 to 40°C (32 to 104°F)

Storage: -40 to 70°C (-40 to 158°F)

Humidity

 

 

Operating: 10 to 95% RH at 40°C (104°F), non-condensing

Storage: 10 to 95% RH at 60°C (140°F), non-condensing

Altitude Range

Operating: Up to 6,130 m (20,000 ft)

Storage: Up to 15,300 m (50,000 ft)

PERFORMANCE SPECIFICATIONS:

	 	 	 
	Noise (EEG Waveform)

	 	< 0.3 μVRMS (2.0μV peak-to-peak)
	BIS Numeric Update Frequency

	 	Once per second
	Bandwidth

	 	0.25 to 100 Hz (- 3dB)
	Impedance Measurement Range

	 	0 to 999 kOhm
	Input Impedance

	 	>50 Mohm
	Patient Leakage

	 	<10μA
	Measurement Ranges
	 	 

	 	 	 	 	 
	 

	 	Bispectral Index (BIS):
	 	0 to 100
	 

	 	Electromyographic Strength (EMG):
	 	25 to 100 dB, where 1μV2=40dB
	 

	 	Signal Quality Index (SQI):
	 	0 to 100%
	 

	 	Suppression Ratio (SR):
	 	0 to 100%
	 

	 	Spectral Edge Frequency (SEF):
	 	0.5 to 30.0 Hz
	 

	 	Total Power:
	 	40 to 100 dB, where 1μV RMS=40dB
	 

	 	Burst Count:
	 	0 to 30

INTERFACE SPECIFICATIONS:

	 	 	 	 	 
	Communication	 	 
	 

	 	     USB Interface:
	 	Conforms to USB Rev. 1.1 Full-Speed protocol
	 

	 	     Protocol:
	 	Aspect proprietary
	 
	 	 	 	 
	Power	 	12 Vdc +/-25%, 400 mA maximum current draw
	Connector	 	3M Inc. 10120-6000E Connector, 20 position, .050” Mini D Ribbon (or equivalent)

 

 

EXHIBIT C

CONTACT PERSONS/ADDRESSES

Contact Persons and responsibilities at Aspect:

	 	 	 	 	 	 	 
	Person	 	Title	 	Responsibility	 	Email
	Barbara Allard

	 	Director, Global OEM Partnerships	 	Relationship Manager
	 	ballard@aspectms.com
	Joan Rubin

	 	Sr. Director,
Business Dvlmpt and
Strategic Planning
	 	Contract and
Marketing
	 	jrubin@aspectms.com
	Steve Mesrobian

	 	Director, OEM Engineering	 	Project Manager
	 	smesrobian@aspectms.com
	Christine Vozella

	 	Sr. Director, RA/QA
	 	Quality and
Regulatory Matters
	 	cvozella@aspectms.com
	Tom Tramontano

	 	Sr. Support
Representative
	 	Technical Service
	 	ttramontano@aspectms.com

Mailing Address:

Aspect Medical Systems Inc.

One Upland Road

Norwood, MA 02062-1546

USA

Contact Persons and responsibilities at Philips:

	 	 	 	 	 	 	 
	Person	 	Title	 	Responsibility	 	Email
	Steve Bebb

	 	Global Director, Product Marketing	 	Relationship Manager
	 	steve.bebb@philips.com
	Franja Speckenbach

	 	 Product Manager
	 	Marketing
	 	franja.speckenbach@philips.com
	Hauke Schik

	 	Q&R Manager
	 	Quality and
Regulatory
	 	hauke.schik@philips.com
	Ewald Pecher

	 	Product Support Engineer	 	Service and Support
	 	ewald.pecher@philips.com
	Craig Whitson

	 	Contracts Analyst
	 	Contracts
	 	craig.whitson@philips.com

Mailing Address:

Philips Medizinsysteme Boblingen GmbH

Hewlett-Packard-Strasse 2

71034 Boeblingen

Germany

 

 

EXHIBIT D

WARRANTY

Aspect warrants to Philips that the BIS Products (“Warranted Product”) will be free from defects in
workmanship or materials, when given normal, proper, and intended usage for a period of 18 months
from the date of its initial shipment to Philips, or 12 months from the date of resale by Philips,
whichever period first expires (“Warranty Period”). This warranty shall not apply to expendable
components and supply items, such as, but not limited to, cables (except for failures occurring
within 180 days of receipt of shipment to Philips) or disposable items such as a BIS Sensor after
the expiration date marked on the BIS Sensor packaging. This warranty shall also not apply to any
component or workmanship of the Monitor Cable supplied by Philips, or any failure resulting from,
or relating to, the design of a Philips -specific connector (e.g. Multi-connector). Aspect’s
obligations under this warranty are to repair or replace any Warranted Product or part thereof that
Aspect reasonably determines to be covered by this warranty and to be defective in workmanship or
materials, provided that the Warranted Product is returned to the factory with freight prepaid.
Repair or replacement of BIS Products under this warranty does not extend beyond the Warranty
Period.

To request repair or replacement under this warranty, Philips should contact the Aspect Technical
Services contact as defined in Exhibit C. Aspect will authorize Philips to return the Warranted
Product (or part thereof) to Aspect. Aspect shall determine whether to repair or replace Warranted
Products and parts covered by this warranty and all Warranted Products or parts replaced shall
become Aspect’s property. In the course of warranty service, Aspect may, but shall not be
required, to make engineering improvements to the Warranted Product or part thereof. If Aspect
reasonably determines that a repair or replacement is covered by the warranty, Aspect shall bear
the costs of shipping the repaired or replacement Warranted Product to the Philips. All other
shipping costs shall be paid by Philips. Risk of loss or damage during shipments under this
warranty shall be borne by the Party shipping the Warranted Product. Warranted Products shipped by
Philips under this warranty shall be packaged in the original shipping container or equivalent
packaging to protect the Warranted Product. If Philips ships a Warranted Product to Aspect in
unsuitable packaging, any physical damage present in the Warranted Product upon receipt by Aspect
(and not previously reported) will be presumed to have occurred in transit and will be the
responsibility of Philips.

Unless authorized or instructed by Aspect in advance, this warranty does not extend to any
Warranted Products or part thereof: that have been subject to misuse, neglect or accident; that
have been damaged by causes external to the Warranted Product, including but not limited to failure
of or faulty electrical power; that have been used in violation of Aspect’s instructions; that have
been affixed to any nonstandard accessory attachment; on which the serial number has been removed
or made illegible; that have been modified by anyone other than Aspect; or that have been
disassembled, serviced or reassembled by anyone other than Aspect, unless authorized by Aspect.
Aspect shall have no obligation to make repairs, replacements, or corrections which result, in
whole or in part, from normal wear and tear. Aspect makes no warranty (a) with respect to any
products that are not Warranted Products, (b) with respect to any products purchased from a person
other than Aspect or an Aspect authorized distributor or (c) with respect to any product sold under
a brand name other than Aspect.

 

 

Aspect represents and warrants that, to the best of its knowledge after proper due diligence and
inquiry, that the Warranted Product to be provided to Philips for use or distribution by Philips
(including in Philips’ product packages or through a download from Philips’s website, or otherwise)
does not include any items that are subject to Open License Terms, including without limitation,
any Open Source Software. Aspect agrees that it will defend, indemnify and hold harmless Philips
and its customers against any and all losses, damages, costs and expenses arising from a breach by
Aspect of any of its obligations or representations under this paragraph, including, without
limitation, any third party claims in connection with any such breach.

 

 

EXHIBIT E

ASPECT TRADEMARKS

	 	 	 
	Aspect Trademarks	 	Reference
	 
	 	 
	Aspect ®

	 	Aspect is a registered trademark of Aspect Medical
Systems, Inc
	 
	 	 
	A-2000 TM

	 	A-2000 is a trademark of Aspect Medical
Systems, Inc.
	 
	 	 
	Bispectral Index ®

	 	Bispectral Index is a registered trademark of Aspect Medical Systems, Inc.
	 
	 	 
	BIS ®

	 	BIS is a registered trademark of Aspect Medical Systems, Inc.
	 
	 	 
	

	 	BIS logo is a registered trademark of
Aspect Medical Systems, Inc.
	 
	 	 
	BISx TM

	 	BISx is a trademark of Aspect Medical Systems, Inc.
	 
	 	 
	BIS ReadyTM

	 	BIS Ready is a trademark of Aspect Medical Systems, Inc.
	 
	 	 
	BIS VISTA TM

	 	BIS VISTA is a trademark of Aspect Medical Systems, Inc.
	 
	 	 
	

	 	BISx logo is a trademark of Aspect Medical Systems, Inc.
	 
	 	 
	

	 	BIS Ready logo is a registered trademark of
Aspect Medical Systems, Inc.

 

 

EXHIBIT F

Philips Trademarks

	 	 	 
	Philips Trademarks	 	Reference
	 
	 	 
	Philips [TM /®]

	 	Philips is a [registered] trademark of [Koninklijke Philips Electronics
N.V. Corporation (Netherlands)]
	 
	 	 
	IntelliVue ®

	 	IntelliVue is a registered trademark of Koninklijke Philips Electronics
N.V. Corporation (Netherlands)
	 
	 	 
	

	 	Philips logo is a registered trademark of [Koninklijke Philips Electronics N.V. Corporation
(Netherlands)]

 

 

EXHIBIT G

SERVICE, SUPPORT AND REPAIR

Service and Support.

	 	a)	 	Service and Support. Philips shall be responsible for providing installation,
customer training, service and support (including repair) to its end customers for the
Aspect Products sold hereunder and Philips shall bear all related costs incurred for labor,
parts, or travel to perform such service.
	 
	 	b)	 	Central Repair Service. For the term of this Agreement, Aspect agrees to
provide central repair service to Philips for Aspect Products sold hereunder at a charge
and as further detailed below (Repair).
	 
	 	c)	 	Excessive Failure Rate. If the annual failure rate of Aspect’s BISx Kit
excluding out-of-box failures and cables exceeds 9.5% (or such higher rate as may be
applicable based on age of equipment) by more than 50% then Aspect shall reimburse Philips
for any additional cost (including material and labor) incurred by Philips for repairing
the units in excess of the above limit.
	 
	 	d)	 	Service Period. For a period of ten (10) years following the last delivery to
Philips of the applicable Aspect Product ordered by Philips hereunder, Aspect shall make
available repair service (or at Aspect’s sole discretion, exchange units for the Aspect
Products) for purchase by Philips and third party users of the Aspect Products at Aspect’s
then-current prices for such repair services and exchange units. After expiry of this ten
(10) year period, Aspect may, in its sole discretion, continue to supply repair services
(and/or exchange units for the Aspect Products) subject to the mutual written agreement of
the Parties.
	 
	 	e)	 	Service Reporting. Aspect shall maintain a complete record of all repair
activities performed on any Aspect Products received for repair, and will provide Philips
with a monthly report on all service actions including failure and repair statistics at a
sub-assembly levels set forth below (Repair). Service reports for each Aspect Product shall
be sent via email to responsible procurement and technical marketing engineer (contact
persons shown in Exhibit C). Root cause analysis is to be performed and reported by Aspect
in case of abnormal failures, incidents and malfunctions.

Repair

1. Repair Strategy:

Repair of defective units will be carried out by Aspect. The service strategy will be most likely
Full Unit Repair:

- Defective units will be shipped from Philips to Aspect for repair.

- Aspect repairs and ships the units within [**] calendar days to Philips after receipt.

Each repair unit will be labeled with an internal Philips order number and tracking number by
Aspect. Tracking number and maybe other data must be labeled as barcode on the shipment carton by
Aspect.

2. Repair Price:

Repair consists of troubleshooting, repair, full testing (function, performance, safety) + admin

	 	 	 	 	 
	To define for each Aspect Product:	 	 
	Material cost:

	 	Subassemblies/Repair Items
	 	 
	Labor cost:

	 	Troubleshooting	 	 
	 

	 	Testing	 	 
	 

	 	Admin	 	 

Goal for full unit exchange: ARP (Average Repair Price)/ exchange unit

Right for Aspect to revise ARP on an annual basis.

To define: Prices for NEW units/cables/sensors

 

 

3. Handling of Repair Costs:

Philips will pay the then-current ARP and freight costs for any defective unit that is returned to
Aspect. On a regular basis Philips shall determine the number of units under warranty that have
been replaced/repaired and Aspect shall reimburse Philips the ARP + freight costs.

With respect to repaired units with “No trouble found” classification, Aspect shall credit Philips
for the difference between ARP and the following amounts only: Troubleshooting, Testing, Admin +
Freight costs.exv10w1

Exhibit 10.1

TRUBION PHARMACEUTICALS, INC.

INDEMNIFICATION AGREEMENT

     This Indemnification Agreement (“Agreement”) is made as of this ___day of ___, by
and between Trubion Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and
___(“Indemnitee”).

     WHEREAS, the Company and Indemnitee recognize the significant cost of directors’ and officers’
liability insurance and the general reductions in the coverage of such insurance;

     WHEREAS, the Company and Indemnitee further recognize the substantial increase in corporate
litigation in general, subjecting officers and directors to expensive litigation risks at the same
time as the coverage of liability insurance has been severely limited; and

     WHEREAS, the Company desires to attract and retain the services of highly qualified
individuals, such as Indemnitee, to serve as officers and directors of the Company and to indemnify
its officers and directors so as to provide them with the maximum protection permitted by law.

     NOW, THEREFORE, in consideration for Indemnitee’s services as an officer or director of the
Company, the Company and Indemnitee hereby agree as follows:

     1. Indemnification; Contribution. The Company shall indemnify and hold harmless Indemnitee to
the fullest extent permitted by applicable law. In furtherance of the foregoing, and without
limiting the generality thereof:

          (a) Third-Party Proceedings. The Company shall indemnify and hold harmless Indemnitee if
Indemnitee is or was a party or is threatened to be made a party to any threatened, pending or
completed action, suit, proceeding or any alternative dispute resolution mechanism, whether civil,
criminal, administrative or investigative (other than an action by or in the right of the Company)
by reason of the fact that Indemnitee is or was a director, officer, employee or agent of the
Company, or any subsidiary of the Company, or by reason of the fact that Indemnitee is or was
serving at the request of the Company as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise, against expenses (including
attorneys’ fees), judgments, fines and amounts paid in settlement (if such settlement is approved
in advance by the Company, which approval shall not be unreasonably withheld) actually and
reasonably incurred by Indemnitee in connection with such action, suit or proceeding if Indemnitee
acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the
best interests of the Company, and, with respect to any criminal action or proceeding, had no
reasonable cause to believe Indemnitee’s conduct was unlawful. The termination of any action, suit
or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its
equivalent, shall not, of itself, create a presumption that Indemnitee did not act in good faith
and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests
of the Company, and, with respect to any criminal action or proceeding, had reasonable cause to
believe that Indemnitee’s conduct was unlawful.

 

 

          (b) Proceedings By or in the Right of the Company. The Company shall indemnify and hold
harmless Indemnitee if Indemnitee was or is a party or is threatened to be made a party to any
threatened, pending or completed action or suit by or in the right of the Company or any subsidiary
of the Company to procure a judgment in its favor by reason of the fact that Indemnitee is or was a
director, officer, employee or agent of the Company, or any subsidiary of the Company, or by reason
of the fact that Indemnitee is or was serving at the request of the Company as a director, officer,
employee or agent of another corporation, partnership, joint venture, trust or other enterprise,
against expenses (including attorneys’ fees) and, to the fullest extent permitted by law, amounts
paid in settlement actually and reasonably incurred by Indemnitee in connection with the defense or
settlement of such action or suit if Indemnitee acted in good faith and in a manner Indemnitee
reasonably believed to be in or not opposed to the best interests of the Company, except that no
indemnification shall be made in respect of any claim, issue or matter as to which Indemnitee shall
have been adjudged to be liable to the Company unless and only to the extent that the Court of
Chancery of the State of Delaware or the court in which such action or suit was brought shall
determine upon application that, despite the adjudication of liability but in view of all the
circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnity for such
expenses which the Court of Chancery of the State of Delaware or such other court shall deem
proper.

          (c) Mandatory Payment of Expenses. To the extent that Indemnitee has been successful on the
merits or otherwise in defense of any action, suit or proceeding referred to in Subsections (a) and
(b) of this Section 1, or in defense of any claim, issue or matter therein, Indemnitee shall be
indemnified and held harmless against expenses (including attorneys’ fees) actually and reasonably
incurred by Indemnitee in connection therewith.

          (d) Contribution. Whether or not the indemnification provided in this Section 1 is available,
in respect of any threatened, pending or completed action, suit or proceeding in which the Company
is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), the
Company shall pay, in the first instance, the entire amount of any judgment or settlement of such
action, suit or proceeding without requiring Indemnitee to contribute to such payment and the
Company hereby waives and relinquishes any right of contribution it may have against Indemnitee.
The Company shall not enter into any settlement of any action, suit or proceeding in which the
Company is jointly liable with Indemnitee (or would be if joined in such action, suit or
proceeding) unless such settlement provides for a full and final release of all claims asserted
against Indemnitee.

     2. Expenses; Indemnification Procedure.

          (a) Advancement of Expenses. The Company shall advance all expenses incurred by Indemnitee in
connection with the investigation, defense, settlement or appeal of any civil or criminal action,
suit or proceeding referenced in Section 1(a) or (b) hereof. Indemnitee hereby undertakes to repay
such amounts advanced only if, and to the extent that, it shall ultimately be determined that
Indemnitee is not entitled to be indemnified by the Company as authorized hereby. The advances to
be made hereunder shall be paid by the Company to Indemnitee within thirty (30) days following
delivery of a written request therefor by Indemnitee to the Company.

2

 

          (b) Notice/Cooperation by Indemnitee. Indemnitee shall, as a condition precedent to his right
to be indemnified under this Agreement, give the Company notice in writing as soon as practicable
of any claim made against Indemnitee for which indemnification will or could be sought under this
Agreement, provided that no delay in providing such notice shall lessen Indemnitee’s entitlement to
indemnification hereunder except to the extent that such delay actually and materially prejudices
the Company’s ability to defend such claim. Notice to the Company shall be directed to the
President of the Company at the address shown on the signature page of this Agreement (or such
other address as the Company shall designate in writing to Indemnitee). Notice shall be deemed
received three business days after the date postmarked if sent by domestic certified or registered
mail, properly addressed, five business days if sent by airmail to a country outside of North
America; otherwise notice shall be deemed received when such notice shall actually be received by
the Company. In addition, Indemnitee shall give the Company such information and cooperation as it
may reasonably require and as shall be within Indemnitee’s power.

          (c) Procedure. Any indemnification and advances provided for in Section 1 and this Section 2
shall be made no later than thirty (30) days after receipt of the written request of Indemnitee.
If a claim under this Agreement, under any statute, or under any provision of the Company’s
Certificate of Incorporation or Bylaws providing for indemnification, is not paid in full by the
Company within thirty (30) days after a written request for payment thereof has first been received
by the Company, Indemnitee may, but need not, at any time thereafter bring an action against the
Company to recover the unpaid amount of the claim and, subject to Section 13 of this Agreement,
Indemnitee shall also be entitled to be paid for the expenses (including attorneys’ fees) of
bringing such action. It shall be a defense to any such action (other than an action brought to
enforce a claim for expenses incurred in connection with any action, suit or proceeding in advance
of its final disposition) that Indemnitee has not met the standards of conduct which make it
permissible under applicable law for the Company to indemnify Indemnitee for the amount claimed.
However, Indemnitee shall be entitled to receive interim payments of expenses pursuant to
Subsection 2(a) unless and until such defense may be finally adjudicated by court order or judgment
from which no further right of appeal exists. It is the parties’ intention that if the Company
contests Indemnitee’s right to indemnification, the question of Indemnitee’s right to
indemnification shall be for the court to decide, and neither the failure of the Company (including
it Board of Directors, any committee or subgroup of the Board of Directors, independent legal
counsel, or its stockholders) to have made a determination that indemnification of Indemnitee is
proper in the circumstances because Indemnitee has met the applicable standard of conduct required
by applicable law, nor an actual determination by the Company (including its Board of Directors,
any committee or subgroup of the Board of Directors, independent legal counsel, or its
stockholders) that Indemnitee has not met such applicable standard of conduct, shall create a
presumption that Indemnitee has or has not met the applicable standard of conduct. The burden of
establishing that Indemnitee is not entitled to indemnification pursuant to applicable law and this
Agreement shall be on the Company.

          (d) Notice to Insurers. If, at the time of the receipt of a notice of a claim pursuant to
Section 2(b) hereof, the Company has director and officer liability insurance in effect, the
Company shall give prompt notice of the commencement of such proceeding to the insurers in
accordance with the procedures set forth in the respective policies. The Company shall thereafter
take all necessary or desirable action to cause such insurers to pay, on behalf of

3

 

the Indemnitee, all amounts payable as a result of such proceeding in accordance with the
terms of such policies.

          (e) Selection of Counsel. In the event the Company shall be obligated under Section 2(a)
hereof to pay the expenses of any proceeding against Indemnitee, the Company, if appropriate, shall
be entitled to assume the defense of such proceeding, with counsel approved by Indemnitee, upon the
delivery to Indemnitee of written notice of its election to do so. After delivery of such notice,
approval of such counsel by Indemnitee and the retention of such counsel by the Company, the
Company will not be liable to Indemnitee under this Agreement for any fees of counsel subsequently
incurred by Indemnitee with respect to the same proceeding, provided that (i) Indemnitee shall have
the right to employ his counsel in any such proceeding at Indemnitee’s expense; and (ii) if (A) the
employment of counsel by Indemnitee has been previously authorized by the Company, (B) Indemnitee
shall have reasonably concluded that there may be a conflict of interest between the Company and
Indemnitee in the conduct of any such defense, or (C) the Company shall not, in fact, have employed
counsel to assume the defense of such proceeding, then the fees and expenses of Indemnitee’s
counsel shall be at the expense of the Company.

     3. Additional Indemnification Rights; Nonexclusivity.

          (a) Scope. Notwithstanding any other provision of this Agreement, the Company hereby agrees
to indemnify the Indemnitee to the fullest extent permitted by law, notwithstanding that such
indemnification is not specifically authorized by the other provisions of this Agreement, the
Company’s Certificate of Incorporation, the Company’s Bylaws or by statute. In the event of any
change, after the date of this Agreement, in any applicable law, statute, or rule which expands the
right of a Delaware corporation to indemnify a member of its board of directors or an officer, such
changes shall be, ipso facto, within the purview of Indemnitee’s rights and Company’s obligations,
under this Agreement. In the event of any change in any applicable law, statute or rule which
narrows the right of a Delaware corporation to indemnify a member of its board of directors or an
officer, such changes, to the extent not otherwise required by such law, statute or rule to be
applied to this Agreement shall have no effect on this Agreement or the parties’ rights and
obligations hereunder.

          (b) Nonexclusivity. The indemnification provided by this Agreement shall not be deemed
exclusive of any rights to which Indemnitee may be entitled under the Company’s Certificate of
Incorporation, its Bylaws, any agreement, any vote of stockholders or disinterested Directors, the
General Corporation Law of the State of Delaware, or otherwise, both as to action in Indemnitee’s
official capacity and as to action in another capacity while holding such office. The
indemnification provided under this Agreement shall continue as to Indemnitee for any action taken
or not taken while serving in an indemnified capacity even though he may have ceased to serve in
such capacity at the time of any action, suit or other covered proceeding.

     4. Partial Indemnification. If Indemnitee is entitled under any provision of this Agreement
to indemnification by the Company for some or a portion of the expenses, judgments, fines or
penalties actually or reasonably incurred by him in the investigation, defense, appeal or
settlement of any civil or criminal action, suit or proceeding, but not, however, for the total

4

 

amount thereof, the Company shall nevertheless indemnify Indemnitee for the portion of such
expenses, judgments, fines or penalties to which Indemnitee is entitled.

     5. Mutual Acknowledgement. Both the Company and Indemnitee acknowledge that in certain
instances, Federal law or applicable public policy may prohibit the Company from indemnifying its
directors and officers under this Agreement or otherwise. Indemnitee understands and acknowledges
that the Company has undertaken or may be required in the future to undertake with the Securities
and Exchange Commission to submit the question of indemnification to a court in certain
circumstances for a determination of the Company’s right under public policy to indemnify
Indemnitee. To the fullest extent permissible under applicable law, if the indemnification
provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company,
in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether
for judgments, fines, penalties, excise taxes, amounts paid in settlement and/or for expenses
(including attorney’s fees) incurred in connection with any claim relating to an indemnifiable
event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of
the circumstances of such claim in order to reflect (i) the relative benefits received by the
Company and Indemnitee as a result of the event(s) and/or transaction(s) giving rise to such claim;
and/or (ii) the relative fault of the Company (and its directors, officers, employees and agents)
and Indemnitee in connection with such event(s) and/or transaction(s).

     6. Officer and Director Liability Insurance. The Company shall, from time to time, make the
good faith determination whether or not it is practicable for the Company to obtain and maintain a
policy or policies of insurance with reputable insurance companies providing the officers and
directors of the Company with coverage for losses from wrongful acts, or to ensure the Company’s
performance of its indemnification obligations under this Agreement. Among other considerations,
the Company will weigh the costs of obtaining such insurance coverage against the protection
afforded by such coverage. In all policies of director and officer liability insurance, Indemnitee
shall be named as an insured in such a manner as to provide Indemnitee the same rights and benefits
as are accorded to the most favorably insured of the Company’s directors, if Indemnitee is a
director; or of the Company’s officers, if Indemnitee is not a director of the Company but is an
officer. Notwithstanding the foregoing, the Company shall have no obligation to obtain or maintain
such insurance if the Company determines in good faith that such insurance is not reasonably
available, if the premium costs for such insurance are disproportionate to the amount of coverage
provided, if the coverage provided by such insurance is limited by exclusions so as to provide an
insufficient benefit, or if Indemnitee is covered by similar insurance maintained by a subsidiary
or parent of the Company.

     7. Severability. Nothing in this Agreement is intended to require or shall be construed as
requiring the Company to do or fail to do any act in violation of applicable law. The Company’s
inability, pursuant to court order, to perform its obligations under this Agreement shall not
constitute a breach of this Agreement. The provisions of this Agreement shall be severable as
provided in this Section 7. If this Agreement or any portion hereof shall be invalidated on any
ground by any court of competent jurisdiction, then the Company shall nevertheless indemnify
Indemnitee to the full extent permitted by any applicable portion of this Agreement that shall not
have been invalidated, and the balance of this Agreement not so invalidated shall be enforceable in
accordance with its terms.

5

 

     8. Primacy of Indemnification. The Company hereby acknowledges that Indemnitee has certain
rights to indemnification, advancement of expenses and/or insurance provided by [insert name of
investor entity] and certain of its affiliates (collectively, the “Fund Indemnitors”). The Company
hereby agrees (i) that it is the indemnitor of first resort (i.e., its obligations to Indemnitee
are primary and any obligation of the Fund Indemnitors to advance expenses or to provide
indemnification for the same expenses or liabilities incurred by Indemnitee are secondary), (ii)
that it shall be required to advance the full amount of expenses incurred by Indemnitee and shall
be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in
settlement to the extent legally permitted and as required by the terms of this Agreement and the
Certificate of Incorporation or Bylaws of the Company (or any other agreement between the Company
and Indemnitee), without regard to any rights Indemnitee may have against the Fund Indemnitors, and
(iii) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all
claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind
in respect thereof. The Company further agrees that no advancement or payment by the Fund
Indemnitors on behalf of Indemnitee with respect to any claim for which Indemnitee has sought
indemnification from the Company shall affect the foregoing and the Fund Indemnitors shall have a
right of contribution and/or be subrogated to the extent of such advancement or payment to all of
the rights of recovery of Indemnitee against the Company. The Company and Indemnitee agree that
the Fund Indemnitors are express third party beneficiaries of the terms of this Section 8.

     9. Exceptions. Any other provision herein to the contrary notwithstanding, the Company shall
not be obligated pursuant to the terms of this Agreement:

          (a) Claims Initiated by Indemnitee. To indemnify or advance expenses to Indemnitee with
respect to proceedings or claims initiated or brought voluntarily by Indemnitee and not by way of
defense, except with respect to proceedings brought to establish or enforce a right to
indemnification under this Agreement or any other statute or law or otherwise as required under
Section 145 of the Delaware General Corporation Law, but such indemnification or advancement of
expenses may be provided by the Company in specific cases if the Board of Directors has approved
the initiation or bringing of such suit; or

          (b) Lack of Good Faith. To indemnify Indemnitee for any expenses incurred by the Indemnitee
with respect to any proceeding instituted by Indemnitee to enforce or interpret this Agreement, if
a court of competent jurisdiction determines that each of the material assertions made by the
Indemnitee in such proceeding was not made in good faith or was frivolous; or

          (c) Insured Claims. To indemnify Indemnitee for expenses or liabilities of any type
whatsoever (including, but not limited to, judgments, fines, ERISA excise taxes or penalties, and
amounts paid in settlement) which have been paid directly to Indemnitee by an insurance carrier
under a policy of officers’ and directors’ liability insurance maintained by the Company.

          (d) Claims Under Section 16(b). To indemnify Indemnitee for expenses and the payment of
profits arising from the purchase and sale by Indemnitee of securities in violation

6

 

of Section 16(b) of the Securities Exchange Act of 1934, as amended, or any similar successor
statute.

     10. Construction of Certain Phrases.

          (a) For purposes of this Agreement, references to the “Company” shall include, in addition to
the resulting corporation, any constituent corporation (including any constituent of a constituent)
absorbed in a consolidation or merger which, if its separate existence had continued, would have
had power and authority to indemnify its directors, officers, and employees or agents, so that if
Indemnitee is or was a director, officer, employee or agent of such constituent corporation, or is
or was serving at the request of such constituent corporation as a director, officer, employee or
agent of another corporation, partnership, joint venture, trust or other enterprise, Indemnitee
shall stand in the same position under the provisions of this Agreement with respect to the
resulting or surviving corporation as Indemnitee would have with respect to such constituent
corporation if its separate existence had continued.

          (b) For purposes of this Agreement, references to “other enterprises” shall include employee
benefit plans; references to “fines” shall include any excise taxes assessed on Indemnitee with
respect to an employee benefit plan; and references to “serving at the request of the Company”
shall include any service as a director, officer, employee or agent of the Company which imposes
duties on, or involves services by, such director, officer, employee or agent with respect to an
employee benefit plan, its participants, or beneficiaries; and if Indemnitee acted in good faith
and in a manner Indemnitee reasonably believed to be in the interest of the participants and
beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in a manner
“not opposed to the best interests of the Company” as referred to in this Agreement.

     11. Counterparts. This Agreement may be executed in one or more counterparts, each of which
shall constitute an original.

     12. Successors and Assigns. This Agreement shall be binding upon the Company and its
successors and assigns, and shall inure to the benefit of Indemnitee and Indemnitee’s estate,
heirs, legal representatives and assigns.

     13. Attorneys’ Fees. In the event that any action is instituted by Indemnitee under this
Agreement to enforce or interpret any of the terms hereof, Indemnitee shall be entitled to be paid
all court costs and expenses, including reasonable attorneys’ fees, incurred by Indemnitee with
respect to such action, unless as a part of such action, the court of competent jurisdiction
determines that each of the material assertions made by Indemnitee as a basis for such action were
not made in good faith or were frivolous. In the event of an action instituted by or in the name
of the Company under this Agreement or to enforce or interpret any of the terms of this Agreement,
Indemnitee shall be entitled to be paid all court costs and expenses, including attorneys’ fees,
incurred by Indemnitee in defense of such action (including with respect to Indemnitee’s
counterclaims and cross-claims made in such action), unless as a part of such action the court
determines that each of Indemnitee’s material defenses to such action were made in bad faith or
were frivolous.

7

 

     14. Notice. All notices, requests, demands and other communications under this Agreement
shall be in writing and shall be deemed duly given (i) if delivered by hand and receipted for by
the party addressee, on the date of such receipt, or (ii) if mailed by domestic certified or
registered mail with postage prepaid, on the third business day after the date postmarked.
Addresses for notice to either party are as shown on the signature page of this Agreement, or as
subsequently modified by written notice.

     15. Consent to Jurisdiction. The Company and Indemnitee each hereby irrevocably consent to
the jurisdiction of the courts of the State of Delaware for all purposes in connection with any
action or proceeding which arises out of or relates to this Agreement and agree that any action
instituted under this Agreement shall be brought only in the state courts of the State of Delaware.

     16. Choice of Law. This Agreement shall be governed by and its provisions construed in
accordance with the laws of the state of Delaware, as applied to contracts between Delaware
residents entered into and to be performed entirely within Delaware without regard to the conflict
of law principles thereof.

     17. Period of Limitations. No legal action shall be brought and no cause of action shall be
asserted by or in the right of the Company against Indemnitee, Indemnitee’s estate, spouse, heirs,
executors or personal or legal representatives after the expiration of two years from the date of
accrual of such cause of action, and any claim or cause of action of the Company shall be
extinguished and deemed released unless asserted by the timely filing of a legal action within such
two-year period; provided, however, that if any shorter period of limitations is otherwise
applicable to any such cause of action, such shorter period shall govern.

     18. Subrogation. In the event of payment under this Agreement, the Company shall be
subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall
execute all documents required and shall do all acts that may be necessary to secure such rights
and to enable the Company effectively to bring suit to enforce such rights.

     19. Amendment and Termination. No amendment, modification, termination or cancellation of
this Agreement shall be effective unless it is in writing signed by both the parties hereto. No
waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of
any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing
waiver.

     20. Integration and Entire Agreement. This Agreement sets forth the entire understanding
between the parties hereto and supersedes and merges all previous written and oral negotiations,
commitments, understandings and agreements relating to the subject matter hereof between the
parties hereto.

8

 

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above
written.

	 	 	 	 	 	 	 
	 	 	TRUBION PHARMACEUTICALS, INC.	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 
	 	 	[Authorized Signatory]	 	 
	 
	 	 	 	 	 	 
	 

	 	Address:
	 	2401 4th Avenue, Suite 1050

Seattle, WA 98121	 	 

	 	 	 	 	 
	AGREED TO AND ACCEPTED:	 	 
	 
	 	 	 	 
	INDEMNITEE:	 	 
	 
	 	 	 	 
	 	 	 
	Name:
	 	 	 	 
	 

	 	 	 	 

			
	Address:	 	c/o Trubion Pharmaceuticals, Inc.

2401 4th Avenue, Suite 1050

Seattle, WA 98121

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}]]